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ABSTRACT OF THE DISSERTATION 
 
Genomic Analysis of Human Spinal Deformity and Characterization  
of a Zebrafish Disease Model 
 
by 
Jillian Gwen Buchan 
Doctor of Philosophy in Biology & Biomedical Sciences 
Molecular Genetics and Genomics 
Washington University in St. Louis, 2014 
Associate Professor Christina Gurnett, Chair 
 
Scoliosis is characterized by a lateral curvature of the spine that requires long-term 
bracing and invasive spinal surgery in cases with progressive deformity. Some individuals 
develop scoliosis secondary to congenital malformations or syndromic disorders, but most 
scoliosis is considered idiopathic and has no known cause. Adolescent idiopathic scoliosis (AIS) 
onsets in late childhood and causes spinal deformity in approximately 3% of the pediatric 
population.  Despite a strong genetic basis, genetic risk factors for AIS are unknown and the 
pathogenesis remains poorly understood, which has been further hindered by the lack of a 
relevant animal model.  Therefore, we used multiple approaches to better understand the genetic 
and molecular etiology of AIS using human and animal-based studies. 
First, we performed copy number variation analysis on 143 patients with isolated 
scoliosis using the Affymetrix Genome-wide Human SNP Array 6.0.  We identified a 
duplication of chromosome 1q21.1 in 2.1% (N=3/143) of AIS patients, which was enriched 
compared to 0.09% (N=1/1079) of controls (P=0.0057) and 0.07% (N=6/8329) of published 
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controls (P=0.0004).  Other notable findings include trisomy X, which was identified in 1.8% 
(N=2/114) of female AIS patients, and rearrangements of chromosome 15q11.2 and 16p11.2 that 
may be relevant to scoliosis susceptibility.  We also report rare CNVs that will be of use to future 
studies investigating candidate genes for AIS. 
Second, we performed a genome-wide rare variant burden analysis using exome sequence 
data and identified FBN1 (fibrillin-1) as the most significantly associated gene with 
AIS.  Mutations in FBN1 are most frequently association with Marfan syndrome, a syndromic 
condition that causes scoliosis in 60% of patients.  Based on these results, FBN1 and a related 
gene, FBN2 (fibrillin-2), were sequenced in a total of 852 AIS cases and 669 controls.  In 
individuals of European ancestry, rare variants in FBN1 and FBN2 were enriched in severely 
affected AIS cases (7.6%) compared to in-house controls (2.4%) (OR=3.5, P=5.46×10-4) and 
Exome Sequencing Project controls (2.3%) (OR=3.5, P=1.48×10-6).  Scoliosis severity in AIS 
cases was associated with FBN1 and FBN2 rare variants (P=0.0012) and replicated in an 
independent Han Chinese cohort (P=0.0376), suggesting that rare variants have utility as 
predictors of curve progression.  Clinical evaluations revealed that the majority of AIS cases 
with rare FBN1 variants do not meet diagnostic criteria for Marfan syndrome, though variants 
are associated with tall stature (P=0.0035) and upregulation of the TGF-β pathway.  
 Finally, we characterized a recessive zebrafish mutant, called skolios, which develops a 
spinal deformity phenotype that parallels many features of human AIS, including an isolated 
lateral curvature of the spine that arises independent of congenital vertebral malformations. 
Skolios was identified in a mutagenesis screen and previously mapped to a 2.7 Mb region on 
chromosome 17.  Because skolios may be an informative model of scoliosis, we sought to 
identify its genetic basis.  We performed low coverage whole genome sequencing on a skolios 
xi 
 
mutant and identified a single nonsense mutation in the mapped region, which caused a 
premature stop in kinesin family member 6 (kif6), a poorly characterized kinesin of unknown 
function.  To determine if the loss of kif6 is responsible for the skolios phenotype, we used 
TALENs to create additional mutant alleles.  We isolated three new TALEN-induced mutations 
that caused frameshift mutations in kif6.  All zebrafish homozygous or compound heterozygous 
for kif6 frameshift mutations developed body axis curvature that was indistinguishable from 
skolios mutants, verifying kif6 as the causative gene.  Preliminary investigation into the 
mechanism of spinal deformity revealed no association with vertebral malformations or cilia 
defects in skolios mutants. 
 Overall, these results identify important genetic risk factors for AIS, including clinically 
relevant copy number variants and rare genetic variation in FBN1 and FBN2.  Moreover, we 
have identified an animal model with scoliosis and demonstrated a novel role for kif6 in the 
developing spine.  These findings have significant impact on our understanding of the genetic 
basis of AIS and reveal new strategies to identify and treat AIS. 
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Chapter 1:  
Introduction and Perspective 
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Scoliosis 
 Spinal deformity is a general term that encompasses several conditions where the spine is 
abnormally curved or misaligned.  Scoliosis is a form of spinal deformity that causes a complex, 
three-dimensional curvature of the spine, with the predominate deviation from the midline 
occurring in the frontal plane (Figure 1.1).  Scoliosis is therefore quantified by the degree of 
lateral curvature.  The Cobb method is the standard and most reliable method of assessing the 
magnitude of spinal curvature in scoliosis and is quantified by measuring the angle, also called 
the Cobb angle, formed between lines drawn parallel to the most tilted vertebrae on a standing 
radiograph (Figure 1.2) [1,2].  Slight variation in the curvature of the spine is normal in the 
population; thus, pathological scoliosis is defined as curves measuring ≥10° using the Cobb 
method [3].   
 
Scoliosis classification 
 Scoliosis is classified by the associated etiology, if known, and can be divided into four 
general categories: congenital, neuromuscular, syndromic and idiopathic (Table 1.1).  In 
congenital scoliosis, spinal curvature is secondary to malformations of the vertebrae, such as 
wedge-shaped vertebrae and hemivertebrae [4].  These vertebral malformations occur early in 
development and are caused by defects during somatogenesis, which can result in imbalanced 
spinal growth and scoliosis [5].   
In neuromuscular and syndromic scoliosis, scoliosis arises secondary to a primary, 
systemic condition.  For example, scoliosis is common in certain neuromuscular conditions, 
including 20-25% of patients with cerebral palsy [6] and 75-90% of patients with Duchenne’s 
muscular dystrophy [7].  Similarly, scoliosis is a common feature of several syndromic 
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conditions, including 63% of patients with Marfan syndrome [8], which also causes a variety of 
other cardiovascular, pulmonary, ocular and skeletal phenotypes.   
When congenital, neuromuscular and syndromic origins of scoliosis have been ruled out, 
scoliosis is considered idiopathic.  Idiopathic scoliosis is therefore a diagnosis of exclusion that 
typically occurs as an isolated condition in otherwise healthy individuals.  Approximately 80% 
of all scoliosis is classified as idiopathic. Some patients with idiopathic scoliosis are identified 
early in life (0-9 years).  However, in the majority of cases, scoliosis is detected in late childhood 
with progression coinciding with pubertal growth in adolescence.  Thus, idiopathic scoliosis that 
is identified in late childhood is further categorized as adolescent idiopathic scoliosis (AIS). 
 
Adolescent idiopathic scoliosis 
AIS affects up to 3% of all children and is generally defined as pathological scoliosis of 
unknown etiology that onsets after the age of 10.  Mild deformity (curves measuring 10-20°) 
affects males and females at similar frequencies [9].  Spinal curvature measuring >20° is less 
common, with the most severe curves being the least frequent (Figure 1.3).  There is a female 
bias in AIS patients with severe curves.  In patients with curves measuring >40°, the females-to-
male ratio is 10:1 [9].  Anthropometric studies have attempted to characterize other physical 
observations in children with AIS.  Such studies have noted reduced body mass index in both 
female and male AIS patients [10,11].  AIS children are also typically taller than normal, age-
matched children, which is enhanced when lost height due to curvature is also factored into 
measurements [12,13].  
In most cases, AIS causes only mild deformity that rarely worsens after skeletal maturity 
[14].  Therefore, mild scoliosis is not typically treated.  AIS causing moderate (20-40°) and 
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severe (>40°) scoliosis has been associated with impaired lung function, resulting in reduced 
forced expiratory volume and forced vital capacity [15-17].  Severe scoliosis can also lead to 
spinal stenosis with radiculopathy, functional limitations, back pain and cause a deformed 
appearance that can be psychologically damaging [18-22].  Moreover, AIS measuring >30° 
continues to worsen after skeletal maturity, at an average of 1° per year [14].  Therefore, 
treatment is often necessary to improve quality of life and reduce the risk of negative physical 
and psychological outcomes in AIS patients with moderate and severe deformity.   
Bracing is a nonoperative form of treatment that is considered once curves reach 20-25°.  
There are many types of braces available to treat scoliosis (reviewed in [23]), but all braces are 
designed to align the spine using external force with the goal of limiting progression and 
correcting existing scoliosis.  Compared to other types of scoliosis (e.g. congenital, 
neuromuscular), AIS patients are the most likely to benefit from bracing [23], which has been 
shown to effectively limit curve progression in some AIS patients [24].   
When nonoperative treatments fail, surgery is considered, typically once curves exceed 
40-45°.  Surgical correction of scoliosis is most frequently achieved through the placement of 
instrumentation and spinal fusion (Figure 1.4) (reviewed in [25,26]).  More than 18,000 children 
undergo major spinal surgery annually because of severe scoliosis [27].  While surgery is an 
effective way to correct AIS and prevent further progression of the deformity, there is a risk of 
complications.  In a study of 702 patients who had surgical correction of AIS, non-neurologic 
complications (e.g. infection, excessive bleeding) occurred in 15.4% of patients [28].  In a 
separate study, 1,301 AIS patients who underwent spinal surgery were assessed for neurological 
complications (e.g. spinal cord injury), which occurred in 0.69% of AIS patients [29].  Because 
surgical correction of AIS is invasive and could potentially lead to complications, bracing is 
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often prescribed in patients at risk for progression to prevent the need for surgery.  Overall, about 
10% of AIS patients develop a deformity resulting in bracing or surgery [30].  Risk factors for 
progressive AIS include skeletal immaturity, female gender and larger spinal curvature at initial 
diagnosis [31].   
 
Genetics of AIS 
The pathogenesis of AIS is poorly understood.  Many diverse models for the etiology of 
AIS have been proposed, including defects in melatonin signaling, asymmetric development of 
the spine coupled with biomechanical factors, low bone mass, abnormal estrogen levels, 
shortened spinal cord, muscle imbalances and many others (reviewed in [32-35]).  Among these 
models, no single concept is preferred as the direct cause of AIS.  Instead, AIS is considered a 
multifactorial disorder that could arise from multiple etiologies.  
Though the pathogenesis of AIS is disputed, it is well accepted that AIS has a genetic 
basis.  It has been recognized since the late 19th century that spinal curvatures tend to run in 
families [36].  At least 26% of AIS patients have one or more affected relatives [37], with 6-11% 
of first-degree relatives affected [37,38], which exceeds what would be predicted based on AIS 
frequencies in the general population.  Additionally, monozygotic twins demonstrate higher 
concordance for AIS (73%) compared to dizygotic twins (36%) [39].  Curve severity is also 
significantly correlated in monozygotic twins [39].   
Dominant autosomal and dominant X-linked inheritance has been described [32,40-42], 
but most AIS families demonstrate complex, non-Mendelian inheritance.  Emerging views of 
AIS heritably favor a complex genetic model with large genetic heterogeneity [32,43-46].  With 
substantial variation in curve magnitude, rates of progression, age of onset and morphology of 
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the deformity among AIS patients, it is also possible that some of these factors arise from 
different genetic factors.  For example, Cheng et al. [47] proposed a two-step model for the 
development of progressive deformity.  In the model, predisposition genes contribute to the 
overall susceptibility to AIS, while different disease modifier genes contributing to the risk of 
progressive scoliosis (Figure 1.5).  Though additional studies are needed to support this two-step 
model, it demonstrates the potential complexity underlying the genetics of AIS.  
 
AIS linkage studies 
Numerous family-based linkage associations have been reported in AIS (reviewed in 
[48]).  Parametric studies of large, single or multi-families have identified several loci that were 
significantly linked to AIS, including 3q12.1 [49], 5q13.3 [49], 9q31.2-q34.2 [50], 12p [51], 
17p11.22 [52], 19p13.3 [53] and Xq22.3-q27.2 [42].  Nonparametric studies have identified 
significant linkage regions at 6q15-q21 [54] and 10q23-q25.3 [54].  The genes within these loci 
relevant to AIS susceptibility have not been determined. 
Miller et al. [55] completed a genome-wide screen with 1,198 individuals in 202 AIS 
families that had two or more affected individuals.  In the study, 391 microsatellite markers 
spaced on average 9 cM apart were genotyped to assess linkage in each family.  Analysis of all 
families under multiple models generated varying linkage results depending on the assumptions 
made (model independent vs. autosomal dominance, AIS as a quantitative vs. qualitative trait, 
varying severity thresholds).  The overall findings indicated four major candidate regions on 
chromosome 6, 9, 16 and 17.  It was also noted that a subset of families with more severe curves 
showed evidence of linkage to chromosome 19, though this locus was less significant when all 
families were included in the analysis [55].  This subgroup was later studied in greater detail and 
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verified to overlap with the 19p13 region identified by Chan et al. [53], containing several 
candidate genes such as fibrillin-3 and thromboxane A2 receptor [56].  Similarly, chromosome 
9q31-q34 was first identified by Miller et al. [55] and identified independently in a linkage study 
of a five generational family with eight affected individuals [50]. 
Wise et al. [57] identified linkage from a single Caucasian family on chromosome 18q 
with a multipoint nonparametric LOD score of 8.26.  Gurnett et al. [58] performed linkage 
analysis on a five-generational Caucasian family with AIS affecting thirteen females and 
identified a novel chromosome 18q12.1-q12.2 locus with a parametric LOD score of 3.31, which 
was encompassed by the region from Wise et al. [56].  Pectus excavatum, a deformity causing 
abnormal growth of the ribs and sternum, was also present in one additional female and three 
male family members.  Interestingly, scoliosis and pectus excavatum are often associated [59]. 
When family members with pectus excavatum were included in the analysis by Gurnett et al. 
[58] as affected, the LOD score increased to 3.86.  Approximately 45 genes were predicted 
within the linkage region, but no coding mutations were identified in 21 genes that were 
resequenced.   
While some progress has been made using linkage analysis, successful linkage studies 
rely on large families with highly penetrant forms of disease in which individuals are 
unambiguously assigned as affected or unaffected.  For diseases such as AIS, with variable 
expressivity and low penetrance, disease status can be difficult to assign in most families.  It has 
been noted in previous AIS studies that reliable diagnosis can only be made if radiographs are 
obtained for all family members, since many mild forms of scoliosis can occur without the 
patient’s knowledge [32,57].  Obtaining radiographs from many individuals in large AIS families 
can be challenging; therefore, the usefulness of linkage analysis is limited in many AIS cohorts.   
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AIS candidate genes 
Further efforts to understand the genetic basis of AIS have focused on candidate gene 
studies.  Most of these studies have yielded mixed results, with both positive and negative 
findings (reviewed in [48]).  Matrilin-1 (MATN1) was selected as a candidate for AIS bases on a 
scoliosis-like phenotype observed in MATN1 mutant mice [60].  MATN1 is an extracellular 
matrix protein that is primarily expressed in cartilage [61].  A microsatellite in the 3’ 
untranslated region (UTR) of MATN1 was over-transmitted from parents to affected probands in 
50 parent-child trios [62].  An association with MATN1 was similarly found in a Chinese 
population [60]; however, no association was identified in a large Japanese population 
containing 789 AIS cases and 1,239 controls [63].   
Genes involved in melatonin signaling have also been a focus of candidate gene studies 
based on findings in animal models (see section below).  Nearly all studies of the melatonin 
receptors 1A (MTNR1A) and 1B (MTNR1B) yielded no association with AIS [63-68], with only 
one study reporting a positive association for MTNR1B [69].   
Because AIS develops during puberty and has a female bias, both forms of the estrogen 
receptors (ESR1 and ESR2) have been implicated as candidate genes.  Polymorphic sites in ESR1 
(encoding ERα) were associated with progression of AIS >5° from initial evaluation and larger 
curves in 304 Japanese females [70].  These results were similarly found in a study of 202 
Chinese AIS patients [71] and 67 Chinese AIS patients with spinal curves measuring ≥30° [72], 
but no association was identified in a study of 540 Chinese AIS patients with curves ≥20° [73].  
ESR2 (encoding ERβ) was associated with AIS susceptibility in 218 patients [74].  However, a 
replication study involving 798 AIS patients and 637 controls of Japanese ancestry found no 
association with polymorphic sites in either ESR1 or ESR2 [75].   
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Gao et al. [76] used linkage analysis from 53 families to identify the chromodomain 
helicase DNA-binding protein 7 gene (CDH7) as a candidate for AIS.  Nonsense, missense and 
splice-site mutations in CDH7 cause CHARGE syndrome (coloboma of the eye, heart defects, 
atresia of the choanae, retardation of growth and/or development, genital and/or urinary 
abnormalities, and ear abnormalities and deafness) [77].  CHARGE syndrome is also associated 
with high rates of scoliosis, which occurs in >60% of CHARGE adolescent and adult patients 
[76,78]; thus, the authors hypothesized that milder mutations could contribute to isolated 
scoliosis in AIS patients.  Sequencing CDH7 in 25 affected patients with AIS did not reveal any 
rare single nucleotide polymorphisms (SNPs) that segregated with disease, although a common 
polymorphism (rs4738824) was shown to have significant overtransmission of the minor allele 
compared to controls [76].  
 
FBN1 and FBN2 as candidate genes for AIS 
Like CDH7 and CHARGE syndrome, other genes causing Mendelian disorders with 
syndromic forms of scoliosis have been considered as candidates for AIS.  Hadley-Miller et al. 
[79] hypothesized that the elastic fiber system of the extracellular matrix may could be a possible 
etiology of AIS, particularly when there are defects in fibrillin.  Fibrillin-1 (FBN1) and fibrillin-2 
(FBN2) are glycoproteins that are the major components of 10nm microfibrils and provide 
structural support to the extracellular matrix [80,81].  Mutations in FBN1 cause Marfan 
syndrome [82], a rare, autosomal dominant disorders that cause scoliosis in 63% of patients [8].  
Marfan syndrome is estimated to occur in 1:5,000-1:10,000 individuals.  Aortic dilation is the 
hallmark feature of Marfan syndrome and predisposes individuals to life-threatening aortic 
aneurysms and dissections [83].  Additional features occur in Marfan syndrome with large 
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phenotypic variability and include ectopia lentis, tall stature, pectus excavatum and carinatum, 
dolichostenomelia, arachnodactyly and joint hypermobility.   
Mutations in FBN2 cause congenital contractural arachnodactyly (also called Beals 
syndrome) [84], an autosomal dominant disorder that causes scoliosis in 50% of patients [85]. 
Congenital contractural arachnodactyly is also rare (<1:10,000) and has phenotypic overlap with 
Marfan syndrome [86].  Many patients with congenital contractural arachnodactyly are described 
as having a Marfanoid appearance, with features such as pectus excavatum and carinatum, tall 
stature, dolichostenomelia and arachnodactyly.  Distinctive features of congenital contractural 
arachnodactyly include “crumpled” ears, muscular hypoplasia and contractures of the major 
joints.  Although congenital contractural arachnodactyly does not appear to be associated with 
the same risk of life-threatening cardiovascular complications as Marfan syndrome, aortic 
dilation has been described in several patients and echocardiographic evaluations are currently 
recommended [87].  
FBN1 and FBN2 are large, complex genes that each consists of approximately 11kb of 
coding sequence spread over 65 exons.  In Marfan syndrome, over 1,000 mutations have been 
described throughout FBN1 [88], with about two-thirds being missense mutations [89].  Most 
pathogenic FBN1 mutations are unique to a family [90] and about 20% are de novo [91].  
Overall, there is little genotype-phenotype correlation within or between families, with the 
exception of the neonatal region of FBN1 (exons 24-32) that is typically associated with a more 
severe, early-onset form of Marfan syndrome [89,92].  The neonatal region is also conserved in 
FBN2 (exons 23-34) and mutations causing congenital contractural arachnodactyly are limited to 
this region [87].  Overall, mutations causing congenital contractural arachnodactyly are 
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considerably less common than those causing Marfan syndrome, with only about 40 FBN2 
mutations having been described [87,93-95].   
Although Marfan syndrome and congenital contractural arachnodactyly are considered to 
be highly penetrant, autosomal dominant disorders, FBN1 mutations have been described in 
families with isolated kyphoscoliosis [96] and isolated skeletal features including scoliosis [97].  
This suggests that fibrillin could play a role in isolated scoliosis.  Hadley-Miller et al. [79] 
investigated FBN1 with histological specimens collected from AIS patients during surgery.  
Immunohistochemical staining of FBN1 from ligamentum flavum showed disorganized and/or 
reduced staining in 82% (N=18/22) of AIS patients compared to controls, which occurred 
independent of the site of biopsy (e.g. concave, convex, apical of the curve) (Figure 1.6).  
Similarly, cultured fibroblasts from AIS patients showed that 17% (N=4/23) of specimens 
secreted fibrillin that failed to incorporate into the extracellular matrix.  Linkage analysis from 
eleven pedigrees containing 96 individuals did not support segregation of the FBN1 locus with 
AIS, although segregation within a single family could not be ruled out [98].  Because of the 
prohibitively high cost of sequencing these large genes, no further genetic studies of FBN1 or 
FBN2 have been pursued in patients with AIS.   
 
AIS genome-wide association studies 
Genome-wide association studies (GWAS) rely on the ‘common disease, common 
variant’ (CDCV) hypothesis, which argues that common variants in the population, typically 
with low disease penetrance, are major contributors to common diseases.  Several GWAS have 
been performed with AIS cohorts to identify common risk loci.  Sharma et al. [99] performed a 
GWAS on 419 Texas AIS families with 1,122 individuals and identified common genetic 
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polymorphisms associated with AIS near the close homologue of L1 (CHL1) gene, although this 
locus did not reach genome-wide significance.  CHL1 is involved in axonal guidance and 
neuronal migration [100,101] and Sharma et al. [99] hypothesized CHL1 could be a good 
candidate for AIS based on evidence that incorrect axonal targeting can cause the autosomal 
recessive disorder horizontal gaze palsy with progressive scoliosis.  Horizontal gaze palsy with 
progressive scoliosis is caused by homozygous or compound heterozygous mutations in a similar 
axonal guidance gene, roundabout homolog 3 (ROBO3) [102].  Interestingly, other genes 
involved in axonal guidance pathways were also among the top associations, including down 
syndrome cell adhesion molecule (DSCAM) and contactin-associated protein-like 2 (CNTNAP2) 
[99]. 
A second GWAS was performed in 1,376 Japanese females with AIS and 11,297 female 
controls [103].  Three common SNPs (rs11190870, rs625039, rs11598564) near the ladybird 
homeobox 1 (LBX1) gene were highly associated with AIS in this cohort, reaching genome-wide 
significance.  Further analysis of LBX1 by reverse transcription polymerase chain reaction (RT-
PCR) showed LBX1 was expressed in human fetal skeletal muscle and spinal cord.  Takahashi et 
al. [103] hypothesized that LBX1 could lead to scoliosis through abnormal somatosensory 
function.  The most significant SNP near LBX1 (rs11190870) replicated in independent cohorts 
consisting of 300 AIS patients and 788 controls in a southern Chinese population [104] and 949 
AIS patients and 976 controls in a Han Chinese population [105].  The association replicated for 
all three SNPs in a cohort of 513 AIS patients and 440 healthy controls from a Han Chinese 
population [106].  However, only one SNP (rs11598564) was among the top 100 SNPs 
associated with AIS in the Sharma et al. [99] study, which contained mostly individuals of 
European ancestry, suggesting possible genetic heterogeneity among ancestral backgrounds. 
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The Japanese GWAS from Takahashi et al. [103] was extended by Kou et al. [107], 
identifying six additional SNPs with suggestive evidence for association with AIS.  One of these 
SNPs (rs6570507) reached genome-wide significance after association testing was performed in 
an independent cohort of AIS cases and controls. This SNP is in the intron of G protein-coupled 
receptor 126 (GPR126).  GPR126 was expressed in proliferating chondrocytes in mice and the 
authors suggest that GPR126 could affect AIS susceptibility through abnormal skeletal growth. 
 
Animal models for AIS 
The genetic and molecular basis of AIS has been difficult to identify, which is in part 
attributed to the lack of a relevant animal model.  Most animal models of AIS have been 
primarily limited to experimental forms of scoliosis, where scoliosis is induced by invasive 
surgical procedures, immobilization or the use of the systemic agents (reviewed in [108]).  One 
of the most extensively studied models of experimentally-induced scoliosis is pinealectomy in 
chickens.  First noted by Thillard [109] in 1959, surgical removal of the pineal gland in the first 
few days after chicks hatch caused chickens to develop scoliosis that progressed until sexual 
maturity [110].  The cause of scoliosis was hypothesized to be due to altered melatonin 
signaling, although later studies showed that chickens with suppressed melatonin secretion by 
constant light did not develop scoliosis [111].  Pinealectomy did not cause scoliosis in rats [112], 
unless pinealectomized rats were also made bipedal through amputation of the forelimbs [113].  
This finding has led to speculations that bipedalism may be an important consideration for 
modeling AIS pathogenesis.  However, pinealectomy in guppy [114] and salmon [115] induces 
scoliosis, indicating that the pinealectomy model of experimentally-induced scoliosis is not 
exclusive to bipedalism.  
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Because spinal deformity develops secondary to harsh interventions, animal models with 
experimentally-induced forms of scoliosis are unlikely to recapitulate many features of human 
AIS.  Few animal models with sporadic, naturally occuring scoliosis have been identified.  One 
long-term study utilized a stock of chickens that were normal at birth but developed a scoliotic 
phenotype as they approached sexual maturity [116].  Over 10 years, McCarrey et al. [116] 
selected for scoliosis to create inbred scoliotic stocks and found that long-term selection 
increased the incidence of scoliosis to 88.5%, but did not affect curve severity.  Though the study 
provided evidence for a major gene affect, follow-up studies to identify the genes have not been 
performed.   
More recently, a possible genetic model for scoliosis was identified in the guppy 
(Poecilia reticulata).  A single male guppy with spinal curvature was isolated from a laboratory 
stock and crossed to generate a lineage called curveback [114].  Of curveback fish born with 
normal spines, 79% developed curves within 2 weeks.  The age of onset, curve magnitude and 
progression varied.  Severe spinal curvature was observed in a higher percentage of females than 
males.  Numerous crossing schemes suggested that the curveback phenotype has complex 
inheritance, with a major gene and modifiers, some of which may be sex-linked.  While 
curveback may prove to be a useful model for AIS, the genes causing the curveback phenotype 
and the potential association to human AIS remain to be elucidated. 
 
Current understanding of AIS 
In the past decade, discovery of disease-causing variants was most often achieved 
through linkage, candidate gene sequencing and association studies.  These same approaches 
have been utilized in the pursuit of genetic variants associated with AIS.  Through linkage 
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studies, several loci associated with AIS have been successfully identified.  However, these 
regions have been large, containing many genes and the specific gene(s) relevant to AIS within 
these loci remain unknown.  Candidate gene studies have yielded mixed findings, with most gene 
associations failing to replicate in other AIS cohorts.  While this may be the result of large 
genetic heterogeneity between ancestral populations or endophenotypes unaccounted for in 
replication cohorts, many studies evaluating AIS candidate genes have used case-control designs 
with small sample sizes.  Thus, additional studies involving larger cohorts of patients are needed 
to resolve previous findings.  GWAS has successfully identified common variants in LBX1 
associated with AIS in a large Japanese cohort [103], which replicated in independent AIS 
cohorts from other Asian ancestries [104-106].  However, it is unclear if LBX1 is associated with 
AIS in other ancestral populations.  Furthermore, common polymorphisms account for only a 
small amount of AIS heritability, suggesting that other forms of genetic variation are likely at 
play and may have a larger role in AIS susceptibility.  Though progress has been made, overall, 
the genetic basis of AIS remains poorly understood.  As an added challenge, few animal models 
have been described and it is currently unclear which species are appropriate to model genetic 
findings in human. 
 
Dissertation objectives 
The objective of the research presented here is to identify additional genetic risk factors 
for AIS, especially rare genetic variants that have not been adequately evaluated as a potential 
cause of disease.  Our study design will address the ‘common disease, rare variant’ (CDRV) 
hypothesis, which states that common diseases are likely due to rare variants of higher 
penetrance [117].  First, we will evaluate rare genomic copy number variants in a cohort of AIS 
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cases.  Rare copy number variation is an established cause of human disease, yet genomic 
deletions, duplications and chromosomal aneuploidy have never been explored as a potential risk 
factor for AIS.  Second, we will utilize the recent advances in next generation sequencing 
technology and DNA enrichment to evaluate rare disease-causing sequence variants (single base 
mutations and small insertion/deletions) on a genome-wide scale.   
The second major objective of this dissertation is to evaluate zebrafish as a potential 
animal model for AIS using an ENU-forward genetic screen.  Naturally occurring scoliosis has 
been demonstrated in the guppy; therefore we hypothesize that the zebrafish, a highly tractable 
animal model with diverse molecular and genetic resources, is an ideal model to identify new 
mutant strains that could illuminate new candidate genes and molecular pathways that also play a 
role in human AIS. 
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Figure 1.1: Scoliosis spinal deformity 
Graphic showing the appearance of normal spine (left) and a spine with scoliosis (right).  Figure 
reproduced from [118].   
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Figure 1.2: Schematic demonstrating the Cobb method of measuring spinal curvature in 
scoliosis   
To quantify the magnitude of scoliosis deformity, spinal curvature is measured from frontal 
plane using a standing radiograph.  The curve, or Cobb angle, is the measured angle created 
when lines are drawn parallel to the most tilted vertebrae. Figure reproduced from [27]. 
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Figure 1.3: Prevalence of AIS by severity 
AIS affect 2-3% of the population, but the prevalence decreases with increasing severity. Figure 
reproduced from [27]. 
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Figure 1.4: Preoperative and postoperative radiograph of an AIS patient  
Preoperative radiograph (top) shows a patient with severe scoliosis from the frontal and lateral 
view. Postoperatively (bottom), the placement of instrumentation and spinal fusion has corrected 
the spinal curvature by 60%. Figure reproduced from [119]. 
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Figure 1.5: A proposed genetic model for AIS development  
A two-step model of genetic and environmental factors contributing to AIS development.  
Predisposition genes contribute to the AIS susceptibility whereas disease modifier genes 
contribute to the risk of progression to severe AIS.  Figure reproduced from [47].  
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Figure 1.6: Disorganized and reduced fibrillin staining in AIS   
Immunohistochemical staining of FBN1 in an individual not affected with scoliosis (top) and a 
patient with AIS (bottom).  In the AIS patient, reduced staining and/or disorganization was 
observed in 82% of patients.  Figure reproduced from [31].  
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Table 1.1: Four broad categories of scoliosis 
Scoliosis classification Example(s) 
Congenital Wedge-shaped vertebrae, hemivertebrae 
Neuromuscular Cerebral palsy, Duchenne muscular dystrophy, arthrogryposis, spinal muscular atrophy 
Syndromic Marfan syndrome, Ehlers-Danlos syndrome, congenital contractural arachnodactyly 
Idiopathic Adolescent idiopathic scoliosis 
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Copy Number Variation in Adolescent Idiopathic Scoliosis 
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SUMMARY 
 
Adolescent idiopathic scoliosis (AIS) is a complex genetic disorder that causes spinal 
deformity in approximately 3% of the population.  Candidate gene, linkage and genome-wide 
association studies have sought to identify genetic variation that predisposes individuals to AIS, 
but the genetic basis remains unclear.  Copy number variants (CNVs) are associated with several 
isolated skeletal phenotypes, but their role in AIS has never been assessed.  In this study, we 
determined the frequency of recurrent copy number rearrangements, chromosome aneuploidy 
and rare CNVs in AIS patients.  We performed genomic copy number analysis on 143 patients 
with isolated AIS using the Affymetrix Genome-wide Human SNP Array 6.0.  We identified a 
duplication of chromosome 1q21.1 in 2.1% (N=3/143) of AIS patients, which was enriched 
compared to 0.09% (N=1/1079) of controls (P=0.0057) and 0.07% (N=6/8329) of published 
controls (P=0.0004).  Other notable findings include trisomy X, which was identified in 1.8% 
(N=2/114) of female AIS patients, and rearrangements of chromosome 15q11.2 and 16p11.2 that 
may be relevant to scoliosis susceptibility.  Finally, we report rare CNVs that will be of use to 
future studies investigating candidate genes for AIS.  Overall, our results suggest that 
chromosomal microarray may reveal clinically useful abnormalities in some AIS patients. 
 
 
 
 
 
 
Portions of this chapter are adapted from: Buchan JG, Alvarado DM, Haller G, Aferol H, Miller 
NH, Dobbs MB, Gurnett CA. (2014) “A Role for Copy Number Variation in Adolescent 
Idiopathic Scoliosis.” Clinical Orthopedics and Related Research. Accepted manuscript. 
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INTRODUCTION 
 
Over the past decade, copy number variation has increasingly been recognized as a major 
cause of disease, in what has come to be known as genomic disorders [1].  Genomic disorders 
arise when deletions, duplication or inversions affect gene dosage or proximity to regulatory 
elements such as enhancers [2].  The mutation rate for copy number variants (CNVs) is estimated 
to be two to four magnitudes higher than for point mutations [3].   
CNV analysis has been successfully applied to patients with intellectual disability, 
neuropsychiatric disorders and multiple congenital abnormalities, revealing multiple genes and 
genomic regions contributing to disease susceptibility (reviewed in [4-6]).  In comparison, 
relatively few CNV studies have assessed patients with isolated skeletal phenotypes, though 
CNVs have been associated with idiopathic short stature [7,8], idiopathic clubfoot [9-11], adult-
onset degenerative lumbar scoliosis [12] and bone mineral density [13].  Moreover, a recent 
study showed that recurrent rearrangements of chromosome 16p11.2 are risk factors for non-
idiopathic scoliosis and vertebral abnormalities in children with additional developmental, 
neurological and congenital abnormalities [14].  These results demonstrate the potential for 
recurrent and other rare CNVs to affected skeletal phenotypes, like scoliosis, and warrants 
evaluation of CNVs in patients with AIS.   
In this study, we determine the frequency of copy number rearrangements, chromosome 
aneuploidy, and rare CNVs from a genome-wide CNV screen of 143 AIS patients and report an 
important role for CNVs in AIS pathogenesis.  
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METHODS 
 
Patient samples 
AIS patients were recruited from the Pediatric Orthopedic Surgery clinics at St. Louis 
Children’s Hospital and St. Louis Shriners Hospital for Children.  All patients had spinal curves 
≥10° as measured with the Cobb method [15] on a standing radiograph.  Patients with known or 
suspected scoliosis etiologies (e.g. Marfan syndrome, congenital abnormalities) were excluded.  
Growth parameters were calculated based on data from the National Center for Health Statistics 
(http://www.cdc.gov/nchs/).  Blood or saliva samples were collected for probands and available 
relatives after obtaining informed consent.  DNA isolations were performed using the DNA 
Isolation Kit for Mammalian Blood (Roche, Indianapolis, IN, USA) or the Oragene Purifier 
(DNA Genotek, Kanata, ON, Canada) according to the manufacturer’s instructions.  Replication 
cohorts for chromosome 1q21.1 (N=120) and trisomy X (N=172) included AIS patients recruited 
from St. Louis Children’s Hospital, St. Louis Shriners Hospital for Children and the University 
of Colorado.  Human Subjects Committees at all three institutions approved this study. 
 
CNV analysis  
Copy number analysis was performed for 148 AIS probands and 1079 controls (666  
controls from a bipolar disorder study [16] and 413 idiopathic clubfoot patients [11]) using the 
Genome-wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA).  Copy number calls 
were generated with the Genotyping Console software (Affymetrix Affymetrix, Santa Clara, CA, 
USA) using a reference set of 270 HapMap controls.  AIS samples with contrast quality control 
(QC) <0.04 and median absolute pairwise difference (MAPD) >0.35 or total CNVs >two 
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standard deviations above the average were excluded (N=5).  Analysis of the remaining 143 AIS 
samples was limited to CNVs ≥125kb in size with ≥50 markers and ≤10kb average distance 
between markers.  CNVs with >50% overlap with assembly gaps were removed.  We identified 
rare and novel CNVs by limiting our analysis to CNVs that had <50% overlap with CNVs at 
>1% frequency or with all CNVs, respectively, in the Database of Genomic Variants (release 
2013-07-23, http://projects.tcag.ca/variation) when ≥100 individuals were evaluated.  To 
evaluate known, clinically significant copy number disorders in AIS patients, we identified 
CNVs that overlapped genomic regions associated with recurrent copy number disorders, 
including 45 recurrent genomic disorder regions (<10 Mb) recently examined in a large control 
population [17].  Quantitative PCR (qPCR) using ≥3 PCR primer pairs validated selected CNVs.  
All sequence coordinates are reported using NCBI assembly build 36 (hg18).   
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RESULTS 
 
 To investigate whether CNVs contribute to AIS susceptibility, we evaluated 143 
unrelated AIS patients for CNVs with the Affymetrix Genome-wide Human SNP Array 6.0.  The 
AIS cohort included primarily familial cases with moderate to severe AIS.  The average spinal 
curve (Cobb angle) for patients in this cohort was 49° and 80% were female (Table 2.1).  To 
enrich our dataset with high confidence CNVs, our analysis was limited to CNVs ≥125 kb in 
size, identified by ≥50 markers with ≤10 kb average distance between markers. 
 
Recurrent copy number rearrangements 
Recurrent rearrangements of chromosome 16p11.2 are associated with scoliosis and other 
abnormalities [14], but this locus has never been evaluated for CNVs in a patient cohort with 
isolated scoliosis and the role of 16p11.2 and other recurrent CNVs in AIS remains unknown.  
Therefore, we identified AIS patients with CNVs overlapping 45 loci associated with recurrent 
copy number disorders [17].  Seven patients (4.9%, N=7/143) in our AIS cohort had CNVs 
overlapping one of the recurrent genomic disorder regions.  These CNVs caused rearrangements 
of chromosome 1q21.1 (N=3), chromosome 2q13 (N=1), chromosome 15q11.2 (N=2) and 
chromosome 16p11.2 (N=1) (Table 2.2). 
  A duplication of chromosome 1q21.1 was the most frequent finding and was present in 
2.1% (N=3/143) of AIS patients compared to 0.09% (N=1/1079) of controls (P=0.0057, one-
tailed Fisher’s exact test) and 0.07% (N=6/8329) of published controls (P=0.0004, one-tailed 
Fisher’s exact test) [17].  After correcting for multiple testing, the enrichment of chromosome 
1q21.1 duplications in AIS remained significant compared to published controls (P<0.001).  
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Large segmental duplication blocks mediate four recurrent breakpoints in chromosome 1q21.1 
CNVs and define distinct proximal and distal regions, but only the proximal region was 
duplicated in all three cases (Figure 2.1).  To test segregation of the proximal 1q21.1 duplication 
with AIS, available family members were evaluated for the presence of the CNV using qPCR.  
The proximal 1q21.1 duplication segregated with reduced penetrance in all three pedigrees 
(Figure 2.2).  AIS ranged in severity from mild to severe in the five affected individuals with the 
duplication (Table 2.3).  Two carriers of the duplication were unaffected, although this was not 
confirmed radiographically.  Clinical information and family histories did not reveal evidence for 
intellectual or developmental disability or other significant comorbidities in the individuals with 
the duplication. 
To screen for additional AIS patients with CNVs in chromosome 1q21.1, we used qPCR 
to identify proximal 1q21.1 CNVs in an independent replication cohort (N=120), but no 
additional chromosome 1q21.1 duplications were identified.  However, even combined with the 
Affymetrix Genome-wide Human SNP Array 6.0 results, the frequency of proximal 1q21.1 
duplications in AIS patients remained enriched compared to controls from this study (N=3/263 
vs. N=1/1079, P=0.0255, one-tailed Fisher’s exact test) and published controls (N=3/263 vs. 
N=6/8329, P=0.0021, one-tailed Fisher’s exact test) [17].   
 
Trisomy X  
 We identified large-scale aneuploidy in 1.4% (N=2/143) of AIS patients.  Both patients 
were female with trisomy of the X chromosome (47, XXX).  Trisomy X was therefore present in 
1.75% (N=2/114) of female AIS patients and was confirmed by qPCR.  Both AIS patients had 
tall stature (>99th percentile), but no additional physical or developmental comorbidities, and 
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neither had previously been diagnosed with this condition.  Only one of 529 females (0.19%) in 
our control cohort was identified with trisomy X, similar the 0.11% frequency observed by 
Nielsen and Wohlert [18] in a large study of 17,038 newborn females.  We screened an 
additional 172 female AIS patients for trisomy X by qPCR and no additional patients were 
identified.  Thus, the overall frequency of trisomy X in AIS females was 0.7% (N=2/286).  
 
Rare CNVs in AIS patients 
 To determine if the overall burden of rare CNVs differs between AIS patients and 
controls, we identified CNVs that occurred at <1% in the Database of Genomic Variants (<50% 
overlap with CNVs present at a frequency of >1% in the Database of Genomic Variants).  We 
identified 177 rare CNVs in 92 AIS patients (Table 2.4).  Of these CNVs, 118 were duplications, 
59 were deletions and the average CNV size was 328 kb.  The frequency of large (>750 kb), 
autosomal CNVs was similar between AIS patients (4.90%, N=7/143) and controls (5.65%, 
N=61/1079).  A complete list of rare CNVs identified in AIS patients is available in Table 2.5.   
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DISCUSSION 
 
Here, we report the first study investigating copy number variation in a cohort of AIS 
patients.  In this study, 6.3% (N=9/143) of AIS patients were identified with chromosomal 
aneuploidy (N=2/143) or a CNV affecting a region previously associated with a recurrent 
genomic disorder (N=7/143).  Our findings illustrate how frequently clinically relevant CNVs 
will be encountered during microarray testing of patients with isolated scoliosis.  Because the 
current study cohort was ascertained in an orthopedic clinic population and because patients with 
obvious developmental and intellectual impairment were excluded from the study, the rate would 
likely have been much higher if patients with additional comorbidities were included.  While 
several of the clinically significant CNVs identified in this study are unlikely to be related to 
AIS, others may have a role in AIS pathogenesis or contribute more generally to multiple spinal 
phenotypes.   
Chromosome 1q21.1 duplications were the most frequently observed chromosomal 
abnormality identified in AIS patients.  Duplications of 1q21.1 were present in 2.1% of AIS 
probands but were found in only 0.07-0.08% of healthy controls [17,19].  Chromosome 1q21.1 
spans a complex 5.4 Mb region of which only 25% contains unique, non-duplicated sequence 
and approximately 700 kb of sequence is missing due to gaps in the NCBI assembly (build 36) 
[20].  Segmental duplications make the region susceptible to recurrent rearrangements by 
nonallelic homologous recombination [21].  The most frequently observed breakpoints arise 
from four large segmental duplication blocks that define two stretches of unique sequence within 
chromosome 1q21.1: the proximal and distal regions located at genomic positions 144 to 144.34 
Mb and 145 to 145.9 Mb, respectively.  The distal region is associated with many phenotypes, 
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including autism [20,22-24], intellectual disability [20,22,25-27], schizophrenia [22,28-33], 
microcephaly and macrocephaly [20,22], congenital heart defects [34-36] and abnormalities in 
the renal and urinary tract [37].  In contrast, there are far fewer disease associations with the 
proximal region.  The strongest association is with thrombocytopenia with absent radii (TAR) 
syndrome [38], which is frequently caused by compound inheritance of proximal 1q21.1 deletion 
and a rare single nucleotide variant in RBM8A [39].  Other phenotypes where proximal 
chromosome 1q21.1 duplications and deletions of varying sizes have been noted include 
congenital heart defects [40-42], Mayer-Rokitansky-Küster-Hauser syndrome [43], autism [44], 
fetal urogenital abnormalities [45] and additional diverse phenotypes [19,46].  Although the three 
AIS patients in our cohort had different chromosome 1q21.1 duplication breakpoints, only the 
proximal region was common to all three individuals and no individuals reported additional 
phenotypes previously associated with chromosome 1q21.1 rearrangements.  Duplications of 
1q21.1 segregated with AIS in small families with incomplete penetrance, but incomplete 
penetrance has also been previously noted in TAR syndrome [38] and other phenotypes [19,47].  
Because additional chromosome 1q21.1 duplications were not detected after screening an 
additional 120 AIS patient samples, proximal duplications are likely rarer in AIS than estimated 
from our original cohort of 143 patients.  Nevertheless, the combined dataset of 263 patients still 
showed a significant enrichment of proximal 1q21.1 duplications in AIS.   
Scoliosis has not been previously described in patients with proximal chromosome 
1q21.1 duplications, though the overall number of patients with this genomic abnormality is 
relatively small.  Scoliosis was not reported in seventeen patients with proximal duplications, 
although two patients had other spine phenotypes (lumbar lordosis and lumbosacral 
hyperlordosis) [19].  Of thirty-four patients with proximal deletions, three had a spinal phenotype 
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(scoliosis, kyphosis and C6-C7 vertebral fusion) [19].  Although previous studies of patients with 
proximal chromosome 1q21.1 duplications suggest that scoliosis is not a commonly associated 
phenotype, scoliosis is often not detected until adolescence and is therefore likely to be 
underreported in younger patient cohorts.  Furthermore, mild scoliosis may be underreported in 
children with multiple congenital anomalies whose other major medical problems are of greater 
concern.  Additional larger studies are needed to determine the importance of  proximal 
chromosome 1q21.1 duplications in the etiology of AIS. 
Several recurrent CNVs identified in our AIS patient cohort are primarily associated with 
cognitive impairment or other related phenotypes, but may also contribute to scoliosis and other 
spinal phenotypes.  Hemivertebrae were present in 20% (N=2/10) of patients with chromosome 
15q11.2 duplications, although none of 15 patients with the reciprocal deletion had vertebral 
abnormalities [48].  Two patients in our AIS cohort had chromosome 15q11.2 CNVs.  
Chromosome 15q11.2 deletions are strongly associated with developmental delay [17], but the 
reciprocal duplication is not and the significance and associated phenotypes of 15q11.2 
duplications, if any, are not well established.  Neurocognitive or developmental phenotypes were 
not present in either of our AIS patients with the 15q11.2 CNVs.   
Likewise, a variety of spinal abnormalities, including hemivertebrae, syringomyelia and 
scoliosis have been described in patients with rearrangements of chromosome 16p11.2 [14,49-
54] and this locus was hypothesized to be a risk factor for idiopathic scoliosis [14].  We 
identified a chromosome 16p11.2 duplication in one AIS patient with spina bifida occulta.  This 
patient did not have intellectual or developmental disability, which is consistent with the large 
phenotypic variability and reduced penetrance observed in individuals with chromosome 
16p11.2 duplications [55].  Interestingly, chromosome 16 was previously associated with 
 44 
 
idiopathic scoliosis by linkage analysis in 202 families [56] and fine-mapping linkage analysis of 
544 individuals from an additional 95 families narrowed the association to two regions on 
chromosome 16, which included 16p11.2 [57], providing further support for an association of the 
16p11.2 locus with AIS.  
We identified trisomy of the X chromosome (47, XXX), also called triple X syndrome, in 
0.7% (N=2/286) female AIS patients.  Triple X syndrome is estimated to occur in 1 of 1,000 
female births and generally causes mild phenotypes, such as premature ovarian failure and 
learning disabilities, which results in many patients being undiagnosed [58].  Scoliosis is well 
known to occur more frequently in triple X syndrome than in the general population [59-61].  
Specifically, Olanders (1977) described scoliosis in 15.2% (N=5/33) of patients with triple X 
syndrome [61].  Patients with triple X syndrome are also typically taller than average, with the 
average height being >80th percentile by the age of fourteen [62].  Both AIS patients with 
trisomy X in our series were tall (>99th percentile for height) but reported no additional 
phenotypes.  Testing for triple X syndrome should be considered in tall females with AIS so that 
other associated phenotypes, such as premature ovarian failure and developmental delay, can be 
monitored.   
There are several limitations to our study, including the relatively small sample size.  For 
the rare CNVs discussed here, a larger sample size would have improved frequency estimates 
and provided more statistical power.  Moreover, in many cases additional family members were 
unavailable for testing and limited our ability to provide additional support for causality.  
Second, controls used in this study included a large number of patients with idiopathic clubfoot 
and CNVs have already been associated with this phenotype [9-11].  However, we also reference 
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the frequency of recurrent CNVs in an even larger published independent control dataset [17] 
and these frequencies are very similar to our control dataset. 
In summary, this study reports the first analysis of copy number variation in a large 
cohort of patients with AIS.  Our data shows that over 6% of AIS patients harbor a clinically 
significant copy number abnormality and many of these are likely risk factors for scoliosis and 
other spinal phenotypes.  Our results suggest that microarray analysis for CNVs may be a useful 
clinical test in this patient population.  Finally, we provide a list of all rare CNVs identified in 
AIS patients, which will be useful for future studies evaluating candidate genes for AIS. 
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Figure 2.1: Proximal chromosome 1q21.1 duplications identified in AIS patients   
Log2 ratios for three AIS probands identified with CNVs at chromosome 1q21.1 show the 
location of the duplications (shaded).  The four recurrent breakpoints (BP1-BP4) and 
approximate locations of the proximal and distal regions are shown.  Image modified from 
Genome Browser (http://genome.ucsc.edu).  All genomic coordinates are shown for NCBI 
assembly build 36 (hg18).   
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Figure 2.2: Segregation of chromosome 1q21.1 duplications  
Duplications segregated in AIS probands (arrows) and family members with reduced penetrance.  
Dup, duplication; -, wild type.    
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Table 2.1: Demographics of 143 AIS probands analyzed for 
copy number variation 
 Familial Non-familial Total 
AIS cases 134 (94%) 9 (6%) 143 
     Male 29 (100%) 0 (0%) 29 (20%) 
     Female 105 (92%) 9 (8%) 114 (80%) 
Cobb angle    
     Mean 49° (n=122) 50° (n=9) 49° (n=131) 
     Range 10-97° (n=122) 26-74° (n=9) 10-97° (n=131) 
  
 
Table 2.2:  Frequency of 45 genomic copy number disorder regions in AIS patients  
Abnormality 
Genomic 
disorder  
region (Mb) 
Size 
(kb) 
AIS patients (this study) Controls (this study) Controls (published) [17] 
Patient(s) Phenotype(s) CNV (Mb) Size  (kb) Frequency Frequency p-value Frequency p-value 
1q21.1  
duplication 
(proximal) 
chr1: 
144-144.34 340 
6041-001 
6267-001 
6035-004 
AIS 
AIS 
AIS 
chr1:142.72-144.97 
chr1:144.08-144.50 
chr1:144.08-144.46 
2241 
420 
379 
2.10%  
(n=3/143) 
0.09%  
(n=1/1079) 0.0057 
0.07% 
(n=6/8329) 0.0004 
2q13  
duplication 
chr2: 
110.18-110.34 160 6126-001 AIS chr2:110.13-110.52 394 
0.70% 
(n=1/143) 
0.65% 
(n=7/1079) 0.6316 
0.38% 
(n=32/8329) 0.4304 
15q11.2  
deletion 
chr15: 
20.35-20.64 290 6053-001 AIS chr15:19.09-21.04 1949 
0.70% 
(n=1/143) 
0.37% 
(n=4/1079) 0.4639 
0.23% 
(n=19/8329) 0.2888 
15q11.2 
duplication 
chr15: 
20.35-20.64 290 6036-001 AIS chr15:20.22-20.97 744 
0.70% 
(n=1/143) 
0.46% 
(n=5/1079) 0.5269 
0.43% 
(n=36/8329) 0.4681 
16p11.2 
duplication 
chr16: 
29.56-30.11 550 6032-001 
AIS, spina  
bifida occulta chr16:29.50-30.09 587 
0.70% 
(n=1/143) 
0.19% 
(n=2/1079) 0.3118 
0.02% 
(n=2/8329) 0.0498 
Genomic coordinates are reported using NCBI assembly build 36 (hg18) 
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Table 2.3:  Clinical information for individuals identified with chromosome 1q21.1 
duplications 
Family Individual Sex 1q21.1  status 
Affected  
(Cobb angle) Curve type Treatment 
6035 004* F Dup/- Yes (15°) NA None 
 002 F Dup/- Yes, mild NA None 
 001 F NA Yes (56°) Right thoracic Surgery 
6041 001* M Dup/- Yes (31°) Right thoracic Brace 
 002 F Dup/- Yes NA Surgery 
 003 F Dup/- No Not affected Not affected 
6267 001* M Dup/- Yes (44°) Right thoracic Surgery 
 002 F -/- No Not affected Not affected 
 003 M Dup/- No Not affected Not affected 
Abbreviations: NA, not available; F, female; M, male; Dup, duplication; -, wild type 
*Proband 
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Table 2.4:  Summary of rare CNVs (<1% frequency in DGV) identified in AIS patients 
AIS patients   143 
AIS patients with rare CNVs 92 
Total rare CNVs 177 
Rare CNVs containing Refseq genes 130 
Average CNV size 328 kb 
Median CNV size 217 kb 
Duplications 118 
Deletions 59 
Large autosomal CNVs (>750 kb) 7 
AIS patients with large CNVs 4.90% 
In-house controls with large CNVs 5.65% 
Abbreviations: DGV, Database of Genomic Variants; CNV, copy number variant 
 
  
 52 
 
Table 2.5: Rare CNVs identified in AIS cases 
Patient 
ID 
Position 
(hg18) CNV 
Size 
(kb) 
# of 
marke
rs 
Distance 
between 
markers 
Genes (Haploinsufficiency index [63]) 
6205-001 chr1:59061626-59195775 Dup 134 105 1 LOC100131060 (NA),  
6278-001 chr1:102428272-102625426 Del 197 152 1 MIR548AI (NA),  
6062-001 chr1:119724173-119956321 Dup 232 232 1 
HAO2 (93.7%), HSD3B2 (NA), HSD3B1 (69.0%), HSD3BP4 
(NA), LINC00622 (NA),  
6041-001 chr1:142724939-144965462 Dup 2241 425 5 
LOC100288142 (NA), LINC00623 (NA), LOC728875 (NA), 
PPIAL4B (NA), PPIAL4C (NA), PPIAL4A (NA), NBPF12 
(NA), PFN1P2 (NA), NBPF8 (NA), NBPF9 (NA), LOC653513 
(NA), PDE4DIP (NA), SEC22B (NA), NOTCH2NL (NA), 
HFE2 (8.3%), TXNIP (46.2%), POLR3GL (66.1%), 
ANKRD34A (NA), LIX1L (27.4%), RBM8A (33.3%), 
GNRHR2 (NA), PEX11B (35.1%), ITGA10 (21.5%), 
ANKRD35 (63.3%), PIAS3 (9.2%), NUDT17 (43.5%), 
POLR3C (32.7%), RNF115 (NA), CD160 (88.1%), PDZK1 
(39.5%), GPR89A (NA), GPR89C (NA), PDZK1P1 (NA), 
LOC728989 (NA),  
6035-004 chr1:144083908-144463196 Dup 379 162 2 
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), HFE2 (8.3%), 
TXNIP (46.2%), POLR3GL (66.1%), ANKRD34A (NA), 
LIX1L (27.4%), RBM8A (33.3%), GNRHR2 (NA), PEX11B 
(35.1%), ITGA10 (21.5%), ANKRD35 (63.3%), PIAS3 (9.2%), 
NUDT17 (43.5%), POLR3C (32.7%), RNF115 (NA), CD160 
(88.1%), PDZK1 (39.5%),  
6267-001 chr1:144083908-144503409 Dup 420 166 3 
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), HFE2 (8.3%), 
TXNIP (46.2%), POLR3GL (66.1%), ANKRD34A (NA), 
LIX1L (27.4%), RBM8A (33.3%), GNRHR2 (NA), PEX11B 
(35.1%), ITGA10 (21.5%), ANKRD35 (63.3%), PIAS3 (9.2%), 
NUDT17 (43.5%), POLR3C (32.7%), RNF115 (NA), CD160 
(88.1%), PDZK1 (39.5%), GPR89A (NA),  
6194-001 chr1:144337051-144463196 Dup 126 53 2 
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), RNF115 (NA), 
CD160 (88.1%), PDZK1 (39.5%),  
6010-001 chr1:144337051-144503409 Dup 166 57 3 
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), RNF115 (NA), 
CD160 (88.1%), PDZK1 (39.5%), GPR89A (NA),  
6041-001 chr1:145574884-147558211 Dup 1983 400 5 
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), GPR89C (NA), 
PDZK1P1 (NA), ACP6 (82.8%), GJA5 (83.7%), GJA8 (NA), 
GPR89B (NA), NBPF11 (NA), NBPF24 (NA), NBPF10 (NA), 
MIR5087 (NA), LOC100130000 (NA), FLJ39739 (NA), 
PPIAL4D (NA), PPIAL4E (NA), PPIAL4F (NA), NBPF14 
(NA), NBPF15 (NA), NBPF16 (NA), LOC645166 (NA), 
NBPF23 (NA), LOC388692 (NA),  
6180-001 chr1:146797048-147349249 Dup 552 57 10 NBPF15 (NA), NBPF16 (NA), LOC645166 (NA),  
6211-001 chr1:146928878-147390822 Del 462 68 7 NBPF16 (NA), LOC645166 (NA),  
6221-001 chr1:146928878-147419014 Del 490 73 7 NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),  
6241-001 chr1:146928878-147419014 Del 490 73 7 NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),  
6293-001 chr1:146928878-147419014 Del 490 73 7 NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),  
6193-006 chr1:146928878-147456930 Del 528 87 6 NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),  
6178-001 chr1:146928878-147469205 Del 540 89 6 NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),  
6053-001 chr1:146929009-147456930 Del 528 84 6 NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),  
6322-001 chr1:147017157-147419014 Del 402 66 6 NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),  
6339-001 chr1:178525369-178657666 Del 132 60 2 ACBD6 (25.1%),  
6044-001 chr1:245244567-245377000 Del 132 70 2 ZNF670 
6068-001 chr2:1395887-1559511 Dup 164 110 1 TPO (51.9%),  
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6240-001 chr2:49389260-49514365 Del 125 112 1  
6237-001 chr2:50774202-51158243 Del 384 255 2 NRXN1 (NA),  
6136-004 chr2:52573819-52705065 Dup 131 117 1  
6028-001 chr2:87026226-87302219 Dup 276 53 5 
RGPD2 (NA), RGPD1 (NA), PLGLB1 (NA), PLGLB2 (NA), 
LOC285074 (NA), MIR4771 
6206-001 chr2:101027972-101981034 Dup 953 518 2 
TBC1D8 (64.4%), CNOT11 (NA), SNORD89 (NA), RNF149 
(82.4%), MIR5696 (NA), CREG2 (82.4%), RFX8 (NA), 
MAP4K4 (21.9%), LOC100506328 (NA), IL1R2 (12.8%),  
6339-001 chr2:184585902-184999185 Del 413 332 1   
6157-001 chr2:236540644-236695522 Dup 155 86 2 AGAP1 (NA),  
6062-001 chr2:238308001-238479991 Del 172 110 2 LRRFIP1 (80.0%), RBM44 (NA), RAMP1 (75.1%),  
6314-001 chr3:537642-882120 Dup 344 228 2  
6157-001 chr3:21204662-21330495 Del 126 89 1   
6029-001 chr3:35780275-35916762 Dup 136 79 2 ARPP21 (NA),  
6304-001 chr3:35780275-35916762 Dup 136 79 2 ARPP21 (NA),  
6306-001 chr3:50406198-50592426 Dup 186 86 2 CACNA2D2 (23.2%), C3orf18 (36.2%), HEMK1 (96.6%),  
6209-001 chr3:126907150-127103540 Dup 196 77 3 MIR548I1 (NA),  
6306-001 chr3:126907150-127112518 Dup 205 78 3 MIR548I1 (NA),  
6303-001 chr3:126907150-127147683 Dup 241 86 3 MIR548I1 (NA), FAM86JP (NA), ALG1L (NA),  
6050-001 chr3:126929342-127103540 Dup 174 72 2 MIR548I1 (NA),  
6213-001 chr3:143303623-143569349 Dup 266 118 2 TFDP2 (2.9%), GK5 (77.4%), XRN1 (11.8%),  
6050-001 chr3:143307337-143569349 Dup 262 116 2 TFDP2 (2.9%), GK5 (77.4%), XRN1 (11.8%),  
6327-001 chr3:162898796-163031671 Del 133 98 1   
6081-001 chr3:164396601-164833278 Del 437 197 2 CT64 (NA),  
6306-001 chr4:3840848-4256969 Dup 416 104 4 FAM86EP (NA), OTOP1 (84.7%),  
6303-001 chr4:3992159-4236511 Dup 244 69 4 FAM86EP (NA),  
6238-001 chr4:3992159-4243961 Dup 252 75 3 FAM86EP (NA), OTOP1 (84.7%),  
6163-001 chr4:4060245-4254791 Dup 195 75 3 OTOP1 (84.7%),  
6206-001 chr4:4066344-4236387 Dup 170 56 3   
6305-001 chr4:69054586-69475447 Dup 421 68 6 UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),  
6233-001 chr4:69054586-69592854 Dup 538 71 8 UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),  
6306-001 chr4:69054586-69592854 Dup 538 71 8 UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),  
6126-001 chr4:69057524-69475447 Dup 418 67 6 UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),  
6194-001 chr4:69057524-69518358 Dup 461 68 7 UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),  
6303-001 chr4:69057524-69592854 Dup 535 70 8 UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),  
6317-001 chr4:69057524-69592854 Dup 535 70 8 UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),  
6206-001 chr4:69096355-69592854 Dup 496 56 9 UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),  
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6085-001 chr4:127358793-127503594 Del 145 100 1  
6303-001 chr4:131801982-132011871 Dup 210 120 2   
6217-001 chr4:135143484-135405069 Del 262 126 2 PABPC4L (NA),  
6293-001 chr4:135190819-135405069 Del 214 98 2 PABPC4L (NA),  
6306-001 chr4:191028537-191254119 Dup 226 58 4 
FRG1 (NA), LOC283788 (NA), FRG2 (NA), LOC100288255 
(NA), DUX4L2 (NA), DUX4L3 (NA), DUX4L4 (NA), 
DUX4L5 (NA), DUX4L6 (NA), DUX2 (NA), DUX4L7 (NA), 
LOC100653046 (NA),  
6219-001 chr5:97281278-97455710 Del 174 91 2   
6010-001 chr5:115241061-115450833 Dup 210 174 1 
AP3S1 (NA), AQPEP (NA), ARL14EPL (NA), COMMD10 
(46.9%),  
6094-001 chr5:137227123-137361288 Dup 134 59 2 MYOT (18.2%), PKD2L2 (33.4%), FAM13B (NA),  
6259-001 chr6:1388098-1633999 Dup 246 208 1 FOXC1 (9.7%), GMDS (54.4%),  
6018-001 chr6:4200744-4416634 Del 216 213 1   
6197-001 chr6:57431738-57781441 Dup 350 157 2 PRIM2 (4.1%),  
6187-001 chr6:67005222-67492828 Del 488 387 1   
6201-001 chr7:4321584-4501323 Del 180 171 1  
6303-001 chr7:9014463-9359327 Dup 345 296 1   
6238-001 chr7:57593474-57736164 Dup 143 56 3  
6094-001 chr7:63726630-63864919 Dup 138 70 2 ZNF107 (NA),  
6300-001 chr7:63777655-63912674 Del 135 56 2 ZNF107 (NA), ZNF138 (NA),  
6171-001 chr7:100753806-100924034 Dup 170 74 2 COL26A1 (NA),  
6289-001 chr7:123003085-123170697 Dup 168 100 2 ASB15 (75.4%), LMOD2 (NA), WASL (4.2%),  
6138-001 chr7:128220854-128399562 Dup 179 71 3 
CCDC136 (79.2%), FLNC (34.3%), ATP6V1F (NA), 
LOC100130705 (NA), KCP (NA), IRF5 (73.9%), TNPO3 
(15.8%),  
6086-001 chr7:142001612-142135250 Del 134 89 2 MTRNR2L6 (NA),  
6178-001 chr8:11101956-11360722 Dup 259 214 1 
MTMR9 (82.9%), SLC35G5 (NA), TDH (NA), C8orf12 (NA), 
FAM167A (NA),  
6337-001 chr8:39740335-41221920 Dup 1482 1129 1 
ADAM2 (53.0%), IDO1 (NA), IDO2 (NA), C8orf4 (43.8%), 
ZMAT4 (22.1%),  
6125-001 chr8:53552367-53895567 Dup 343 201 2 FAM150A (NA), RB1CC1 (9.0%),  
6337-001 chr8:53571918-54677369 Dup 1105 745 1 
FAM150A (NA), RB1CC1 (9.0%), NPBWR1 (78.3%), OPRK1 
(69.1%),  
6138-001 chr8:53583779-53968156 Dup 384 223 2 FAM150A (NA), RB1CC1 (9.0%),  
6040-001 chr9:28176821-28337679 Del 161 135 1 LINGO2 (4.3%),  
6304-001 chr9:89592787-89744027 Dup 151 94 2 
CTSLP8 (NA), LOC392364 (NA), SPATA31E1 (NA), 
SPATA31C1 (NA),  
6171-001 chr9:119155660-120345735 Dup 1190 920 1 ASTN2 (NA), TLR4 (49.1%),  
6128-002 chr10:35210421-35356001 Dup 146 85 2 CUL2 (10.0%),  
6223-001 chr10:67724031-67879925 Del 156 95 2 CTNNA3 (62.1%),  
6219-001 chr10:68037668-68211255 Del 174 142 1 CTNNA3 (62.1%),  
6211-001 chr10:81775965-81962789 Dup 187 124 2 TMEM254 
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6044-001 chr10:93658958-93822581 Dup 164 76 2 FGFBP3 (NA), BTAF1 (2.3%), CPEB3 (9.7%),  
6233-001 chr10:107089900-107306982 Dup 217 125 2  
6053-001 chr10:107092132-107306982 Dup 215 124 2   
6341-001 chr10:128361479-128559804 Del 198 170 1  
6026-001 chr11:5023934-5170989 Del 147 127 1 OR52J3 (NA), OR52E2 (NA), OR52A5 (NA), OR52A1 (NA),  
6330-001 chr11:49601437-49808604 Dup 207 112 2 LOC440040 (NA),  
6085-001 chr11:55442375-55582755 Del 140 106 1 
OR5I1 (95.5%), OR10AG1 (NA), OR7E5P (NA), OR5F1 (NA), 
OR5AS1 (NA),  
6303-001 chr11:71029775-71201199 Dup 171 51 3 FAM86C1 (NA), ALG1L9P (NA),  
6306-001 chr11:71029775-71205347 Dup 176 53 3 FAM86C1 (NA), ALG1L9P (NA), ZNF705E (NA),  
6206-001 chr11:71029775-71214508 Dup 185 56 3 FAM86C1 (NA), ALG1L9P (NA), ZNF705E (NA),  
6275-001 chr12:71517646-71654142 Del 136 89 2   
6038-001 chr12:89419571-89655818 Del 236 129 2  
6157-001 chr12:98539959-98709344 Del 169 97 2 ANKS1B (51.7%), FAM71C (95.3%),  
6316-002 chr12:112752416-113046826 Dup 294 290 1 RBM19 (42.2%),  
6277-001 chr12:130533535-130710089 Dup 177 181 1   
6121-001 chr13:17943628-18217635 Dup 274 60 5 LINC00417 (NA),  
6205-001 chr13:17943628-18267580 Del 324 70 5 LINC00417 (NA),  
6303-001 chr13:18138676-18316876 Dup 178 77 2 LINC00417 (NA), ANKRD20A9P (NA),  
6317-001 chr13:18184856-18310275 Dup 125 59 2 LINC00417 (NA), ANKRD20A9P (NA),  
6180-001 chr13:19054403-19380872 Dup 326 152 2 MPHOSPH8 (75.4%), PSPC1 (65.3%), ZMYM5 (93.2%),  
6337-001 chr13:33887795-34035511 Dup 148 107 1 LINC00457 (NA),  
6206-001 chr13:54016684-54374043 Del 357 211 2  
6306-001 chr13:75241901-75394225 Dup 152 157 1 LMO7 (89.7%), C13orf45 (NA),  
6073-001 chr14:21524127-22030660 Del 507 438 1  
6330-001 chr14:21555352-21950283 Del 395 344 1   
6121-001 chr14:21575148-22029666 Del 455 389 1  
6171-001 chr14:21656002-21786451 Del 130 135 1   
6036-001 chr14:21656002-22008051 Del 352 296 1  
6085-001 chr14:21660717-22020331 Del 360 312 1   
6086-001 chr14:21664286-22017122 Del 353 305 1  
6044-001 chr14:21668999-21801251 Del 132 141 1   
6216-001 chr14:21697326-21950283 Del 253 215 1  
6234-001 chr14:21697326-22020331 Del 323 266 1   
6033-001 chr14:21711505-21964093 Del 253 204 1  
6035-004 chr14:21721254-21970760 Del 250 198 1   
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6012-001 chr14:21721254-22008051 Del 287 218 1  
6337-001 chr14:21817588-21950283 Del 133 87 2   
6041-001 chr14:42027983-42411046 Dup 383 244 2  
6073-001 chr14:60411971-60589931 Del 178 82 2 MNAT1 (3.1%), TRMT5 (NA), SLC38A6 (95.6%),  
6179-001 chr14:99592280-100113598 Dup 521 246 2 
EVL (7.5%), MIR342 (NA), DEGS2 (NA), YY1 (4.4%), 
SLC25A29 (NA), MIR345 (NA), SLC25A47 (NA), WARS 
(48.9%), WDR25 (58.5%), BEGAIN (NA),  
6068-001 chr15:31753942-32244695 Dup 491 389 1 
RYR3 (37.6%), AVEN (90.0%), CHRM5 (44.2%), EMC7 
(NA), PGBD4 (NA), KATNBL1 (NA),  
6234-001 chr15:43934913-44070720 Del 136 107 1  
6271-003 chr16:4971083-5288139 Del 317 188 2 SEC14L5 (NA), NAGPA (85.5%), 
6218-001 chr16:6082024-6284589 Dup 203 229 1  
6317-001 chr16:14678121-15034391 Dup 356 82 4 
PLA2G10 (71.6%), NPIPA2 (NA), NPIPA3 (NA), ABCC6P2 
(NA), NOMO1 (NA), MIR3179 
6077-001 chr16:14684882-15002197 Dup 317 75 4 
PLA2G10 (71.6%), NPIPA2 (NA), NPIPA3 (NA), ABCC6P2 
(NA), NOMO1 (NA), MIR3179 
6306-001 chr16:14684882-15002197 Dup 317 75 4 
PLA2G10 (71.6%), NPIPA2 (NA), NPIPA3 (NA), ABCC6P2 
(NA), NOMO1 (NA), MIR3179 
6106-001 chr16:14796084-14984969 Dup 189 52 4 ABCC6P2 (NA), NOMO1 (NA), MIR3179 
6298-001 chr16:14796084-14994666 Dup 199 64 3 ABCC6P2 (NA), NOMO1 (NA), MIR3179 
6238-001 chr16:14803686-14987944 Dup 184 55 3 ABCC6P2 (NA), NOMO1 (NA), MIR3179 
6028-001 chr16:14803686-14994666 Dup 191 63 3 ABCC6P2 (NA), NOMO1 (NA), MIR3179 
6322-001 chr16:14846829-14987944 Dup 141 52 3 NOMO1 (NA), MIR3179 
6221-001 chr16:14846829-15002197 Dup 155 66 2 NOMO1 (NA), MIR3179 
6233-001 chr16:14846829-15002197 Dup 155 66 2 NOMO1 (NA), MIR3179 
6126-001 chr16:14888466-15023746 Del 135 64 2 NOMO1 (NA), MIR3179 
6305-001 chr16:16540862-17012694 Dup 472 198 2  
6032-001 chr16:29498829-30085908 Dup 587 198 3 
SLC7A5P1 (NA), SPN (NA), QPRT (NA), C16orf54 (NA), 
ZG16 (NA), KIF22 (NA), MAZ (32.2%), PRRT2 (41.6%), 
PAGR1 (NA), MVP (69.2%), CDIPT (69.0%), CDIPT 
6306-001 chr16:34645472-34832848 Dup 187 52 4  
6301-001 chr16:73926386-74080901 Del 155 75 2 CFDP1 (13.2%), TMEM170A (NA), CHST6 (70.7%),  
6073-001 chr17:692289-837961 Dup 146 82 2 NXN (37.4%),  
6271-003 chr17:15811223-16033881 Dup 223 106 2 
ADORA2B (87.8%), ZSWIM7 (NA), TTC19 (50.4%), NCOR1 
(16.5%),  
6306-001 chr17:20166343-20584318 Dup 418 83 5 
CCDC144CP (NA), LGALS9B (NA), KRT16P3 (NA), 
CDRT15L2 (NA), LOC100287072 (NA),  
6161-001 chr17:21281893-21476920 Dup 195 87 2 C17orf51 (NA),  
6269-001 chr17:21281893-21495308 Dup 213 94 2 C17orf51 (NA),  
6038-001 chr17:28981264-29962135 Dup 981 937 1 
ASIC2 (NA), CCL2 (26.0%), CCL7 (95.8%), CCL11 (99.6%), 
CCL8 (96.3%), CCL13 (99.2%), CCL1 (99.9%), C17orf102 
(NA), TMEM132E (33.5%),  
6123-001 chr17:51455471-51672518 Dup 217 221 1 ANKFN1 (27.1%),  
6306-001 chr18:14103916-14341363 Dup 237 52 5 ZNF519 (NA), ANKRD20A5P (NA), CYP4F35P (NA),  
6300-001 chr18:14139471-14388602 Dup 249 60 4 ANKRD20A5P (NA), CYP4F35P (NA),  
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6033-001 chr18:60260938-60420239 Dup 159 92 2   
6306-001 chr19:12435345-12561674 Del 126 54 2 ZNF709 (NA), ZNF564 (NA), ZNF490 (54.9%),  
6341-001 chr21:34646609-34823160 Dup 177 102 2 
KCNE2 (89.8%), SMIM11 (NA), KCNE1 (76.7%), RCAN1 
(NA),  
6218-001 chrX:2965778-3158320 Dup 193 181 1 ARSF (76.4%),  
6028-001 chrX:6465151-8093257 Dup 1628 1213 1 
HDHD1 (NA), MIR4767 (NA), STS (45.2%), VCX (NA), 
PNPLA4 (64.3%), MIR651 (NA),  
6036-001 chrX:7227969-7412657 Dup 185 135 1 STS (45.2%),  
6233-001 chrX:7373945-7782233 Dup 408 308 1 VCX (NA),  
6316-002 chrX:7799976-8094650 Dup 295 245 1 PNPLA4 (64.3%), MIR651 (NA),  
6233-001 chrX:7812245-8092678 Dup 280 231 1 PNPLA4 (64.3%), MIR651 (NA),  
6202-001 chrX:9408122-9997284 Dup 589 505 1 
TBL1X (NA), GPR143 (79.8%), SHROOM2 (70.2%), 
LOC100288814 (NA), WWC3 (NA),  
6280-001 chrX:56748915-58490459 Del 1742 806 2 
LOC550643 (NA), UQCRBP1 (NA), SPIN3 (NA), SPIN2B 
(43.4%), SPIN2A (NA), FAAH2 (62.4%), ZXDB (NA), ZXDA 
(NA),  
6094-001 chrX:57386443-57517736 Dup 131 68 2 FAAH2 (62.4%),  
6209-001 chrX:58298891-58497269 Dup 198 56 4   
6026-001 chrX:61645542-62073324 Dup 428 68 6  
6278-001 chrX:61645542-62112687 Dup 467 82 6   
6031-001 chrX:65616302-66104307 Dup 488 241 2 EDA2R (NA),  
6274-001 chrX:65678294-65850037 Dup 172 88 2 EDA2R (NA),  
6328-001 chrX:89609426-89831490 Dup 222 60 4  
6077-001 chrX:92273794-92723465 Dup 450 285 2   
6098-001 chrY:14608287-14807693 Dup 199 120 2 VCY (NA),  
6306-001 chrY:25889736-26066330 Dup 177 58 3 GOLGA2P2Y (NA), GOLGA2P3Y (NA), CSPG4P1Y (NA),  
Abbreviations: Dup, duplication; Del, deletion; CNV, copy number variant; ID, identifier 
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Chapter 3:  
Exome Sequencing Identifies Rare Variants in FBN1 and FBN2 Associated 
with Severe Adolescent Idiopathic Scoliosis 
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SUMMARY 
 
Despite a strong genetic basis, few genes have been associated with AIS and the 
pathogenesis remains poorly understood.  In a genome-wide rare variant burden analysis using 
exome sequence data, we identified FBN1 (fibrillin-1) as the most significantly associated gene 
with AIS.  Based on these results, FBN1 and a related gene, FBN2 (fibrillin-2), were sequenced 
in a total of 852 AIS cases and 669 controls.  In individuals of European ancestry, rare variants in 
FBN1 and FBN2 were enriched in severely affected AIS cases (7.6%) compared to in-house 
controls (2.4%) (OR=3.5, P=5.46×10-4) and Exome Sequencing Project controls (2.3%) 
(OR=3.5, P=1.48×10-6).  Scoliosis severity in AIS cases was associated with FBN1 and FBN2 
rare variants (P=0.0012) and replicated in an independent Han Chinese cohort (P=0.0376), 
suggesting that rare variants have utility as predictors of curve progression.  Clinical evaluations 
revealed that the majority of AIS cases with rare FBN1 variants do not meet diagnostic criteria 
for Marfan syndrome, though variants are associated with tall stature (P=0.0035) and 
upregulation of the TGF-β pathway.  Overall, these results expand our definition of fibrillin-
related disorders to include AIS and open up new strategies for diagnosing and treating severe 
AIS. 
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INTRODUCTION 
 
The human exome consists of about 180,000 exons spread across ~38 megabases (Mb).  
Although this represents only 1% of the genome, disrupted protein-coding regions make up 
about 85% of known variation underlying Mendelian disorders [1].  Therefore, exome 
sequencing provides an unbiased, genome-wide approach to identify variation in the regions that 
are most likely to have large affects. 
Rare variants are thought to have a greater contribution to disease risk because negative 
selection restricts variants of large genetic effect from rising to high frequency [2].  We therefore 
hypothesized that rare genetic variants are a major contributor to severe AIS susceptibility.  
Although large-scale sequencing studies are needed to detect rare variants, such studies have 
recently become feasible due to emerging sequencing technologies and reduction in sequencing 
cost.  Using exome sequencing, we first analyzed rare variants genome-wide in a small cohort of 
severe AIS cases and identified FBN1 and FBN2 as candidate genes for AIS, which we then 
sequenced in a larger case and control cohort using a newly described, cost-effective targeted 
capture method.    
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METHODS 
 
Patient samples and controls 
AIS patients were recruited from St. Louis Children’s Hospital, St. Louis Shriners 
Hospital for Children, the University of Iowa, the University of Colorado and the Chinese 
University of Hong Kong.  All patients had scoliosis of unknown etiology with spinal curves 
measuring ≥10°.  Curve measurements are reported for the largest lateral spinal curve using the 
Cobb method [3].  Patients with developmental delay, multiple congenital anomalies or known 
underlying medical disorders (e.g. Ehlers-Danlos syndrome, Marfan syndrome) were excluded.  
We selected 91 unrelated AIS cases of European ancestry with severe deformity (spinal curves 
measuring ≥40° or requiring surgery) for the exome sequencing screen.  Additional AIS cases of 
European (N=344), Han Chinese (N=370) and other ancestries (N=47) were included in 
subsequent analyses.  DNA was collected from affected probands after obtaining informed 
consent.  Growth parameters were calculated using the National Center for Health Statistics 
(http://www.cdc.gov/nchs).  Systemic features of Marfan syndrome and joint hypermobility were 
quantified according to the revised Ghent scoring system [4], and the Beighton scoring system 
[5], respectively, and were obtained in patients without knowledge of genetic sequencing results.  
A subset of AIS cases were recontacted after FBN1 variants previously identified in individuals 
with Marfan syndrome or novel variants of uncertain significance were identified as a part of this 
research study.  These cases were referred to clinical geneticists at St. Louis Children’s Hospital 
and St. Louis Shriners Hospital for Children for evaluation of possible Marfan syndrome.  
Controls for this study consisted of unrelated healthy individuals or patients with 
neurological (e.g. Alzheimer’s disease) or other musculoskeletal disorders without spine 
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involvement (e.g. limb deformity).  For the exome sequencing screen, we selected 337 controls 
of European ancestry.  Additional in-house controls of European (N=249) or Han Chinese 
(N=83) ancestry were included in subsequent analyses.  Individuals of European ancestry 
(N=4,300) were included from the Exome Variant Server, NHLBI GO Exome Sequencing 
Project (ESP) (http://evs.gs.washington.edu/EVS) public database as an additional control cohort 
(ESP6500SI-V2). 
 
Exon enrichment and sequencing 
Exon enrichment was performed using the SureSelect Human All Exon 38Mb and 50Mb 
kits (Agilent Technologies, Santa Clara, California) or the TruSeq Exome Enrichment kit 
(Illumina, San Diego, California).  Exome data was extracted from whole genome sequencing in 
a subset of in-house controls.  Samples were sequenced on a Genome Analyzer IIx or HiSeq 
2000 sequencer (Illumina, San Diego, California) by the Washington University Genome 
Technology Access Center.     
 
Targeted capture of FBN1 and FBN2 
Target enrichment of FBN1 and FBN2 was performed using the Multiplex Direct 
Genomic Selection method (manuscript under review), which utilizes multiplexed capture [6] 
with targeted selection using bacterial artificial chromosomes (BACs) [7] and next-generation 
sequencing.  DNA samples (300ng) were sonicated using a Covaris E210 focus-ultrasonicator 
(Covaris Inc., Woburn, Massachusetts).  Samples were indexed using previously described 
adapter sequences [6].  Indexed samples were pooled in batches of 48-96 prior to capture.  Four 
BACs spanning the entire coding regions of FBN1 (RP11-1144G24 [chr15:48676783-48822143] 
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and RP11-147E14 [chr15:48822351-48985158]) and FBN2 (RP11-909P14 [chr5:127,567,172-
127,756,046] and RP11-351A8 [chr5:127,752,763-127,906,815]) (BACPAC Resources Center, 
Oakland, California) were used as baits.  BACs were biotinylated using nick translation with 
biotin-16-dUTP (Roche Applied Science, Penzberg, Germany).  Pooled samples were hybridized 
with biotinylated BACs.  Dynabeads M-280 Streptavidin (Life Technologies Co., Carlsbad, 
California) were used to isolate BAC-associated DNA.  Post-capture, pooled samples were 
sequenced using a MiSeq Personal Sequencer (Illumina, San Diego, California).  
 
Alignment and variant calling 
Next generation sequencing reads were aligned to hg19 human reference sequence 
(Genome Reference Consortium Human Build 37) using Novoalign software (Novocraft 
Technologies, Selangor, Malaysia).  Variant calling and annotation were completed using 
SAMtools [8] and SeattleSeq Annotation 131 
(http://snp.gs.washington.edu/SeattleSeqAnnotation131), respectively.  All AIS cases and in-
house controls were analyzed using an identical methodology.  
 
Quality control and gene burden analysis 
For all analyses, variants were defined as rare when absent from the dbSNP database 
(build 137).  Analysis was restricted to variants altering the coding sequence (nonsense, splice-
site, missense and insertion/deletion mutations).  We used a collapsing approach to measure gene 
burden [9].  Rare variant burden was quantified as the sum of all variant alleles for each gene 
divided by the total alleles in the population and is expressed as the collapsed minor allele 
frequency (cMAF). 
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For the exome sequencing screen, only AIS cases and in-house controls with ≥90% of the 
exome covered at ≥8X coverage were included in the analysis.  Variant calls were merged at all 
sites and filtered for sites called in >80% of individuals.  Gene burden analysis was performed 
exome-wide for each gene with at least one variant site.   
 For gene burden analysis of FBN1 and FBN2 in the larger dataset, more conservative 
quality thresholds were applied.  Only individual samples with ≥95% of FBN1 (NM_000138) or 
FBN2 (NM_001999) covered at ≥8X read depth were included.  Low quality variants (phred-
scaled quality score <30 or genotype quality score <75) were removed.  Controls from the ESP 
were similarly analyzed using build 137 of the dbSNP database as a filter, which does not 
include individuals from this dataset.  In the Han Chinese patient cohort, variants identified in 
dbSNP or in 83 Han Chinese controls were excluded from analysis.  All rare variants in AIS 
cases were validated by Sequenom MassARRAY (Sequenom, San Diego, California) by the 
Washington University Human Genetics Division of Genotyping Core or by Sanger sequencing 
using an ABI 3730 Sequencer (Life Technologies, Carlsbad, California).  All genotyped variants 
(N=32) validated.   
 
Statistical analysis 
One-tailed P-values <0.05 were considered statistically significant.  A Fisher’s exact test 
was used for all gene burden analyses.  The Shapiro-Wilk test demonstrated non-normally 
distributed clinical characteristics (P<0.05), therefore, the Mann-Whitney-Wilcoxon test was 
used to compare clinical features, except gender and AIS family history, which were compared 
using a Fisher’s exact test.  Statistical tests were performed with GraphPad Prism software 
(http://www.graphpad.com/scientific-software/prism).  
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Protein immunoblotting 
Immunoblotting was performed using paraspinous muscle collected during surgery for 
scoliosis (AIS and Marfan syndrome) or for a ruptured spinal disc in a patient without scoliosis 
(unaffected control).  All samples were collected from females between 9 and 18 years old.  
Denatured protein (200µg) was separated on a 7.5% gel by SDS-PAGE and transferred to a 
nitrocellulose membrane.  Rabbit polyclonal antibody to pSmad2 (1:1,000; EMD Millipore Co.) 
and mouse monoclonal antibody to actin (AC1-20.4.2; 1:2000; Sigma-Aldrich Co.) were used.  
Chemiluminescent signals in AIS cases and Marfan syndrome were quantified using ImageJ 
[10].  Phospho-SMAD2 signal was normalized to actin and the unaffected control.  
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RESULTS 
 
Exome sequencing screen identifies FBN1 and FBN2 as a candidate genes for severe AIS  
 To identify candidate genes for AIS, exome sequencing was performed on 91 AIS cases 
with severe scoliosis (spinal curves measuring ≥40° or surgically treated).  We restricted our 
analysis to AIS patients with severe scoliosis to reduce the likelihood of latent disease in the 
control population, thus increasing power of the association [11].  Furthermore, identifying 
genetic variants associated with severe AIS has important clinical utility.  Cases in this cohort 
had an average spinal curve of 60.2° (SD=15.2°) and 84% were female.  The female bias is 
consistent with previous studies, where female-to-male ratios are estimated to be as high as 10:1 
with severe deformity [12].  Exome sequencing data was also generated for 337 controls.  All 
cases and controls were unrelated and of European ancestry.  Only coding variants that caused 
nonsense, splice-site, missense or insertion/deletion mutations which were rare (defined as being 
absent in dbSNP) were included in the analysis.  This filtering strategy was selected to enrich in 
mutations that are very rare and most likely to be deleterious.   
  Using a gene-burden analysis, we compared the genome-wide frequency of rare coding 
variants in severe AIS cases and controls.  Of nearly 13,000 genes identified with at least one 
rare variant, FBN1 (encoding fibrillin-1) was the most significantly associated gene with AIS 
compared to controls (P=3.17×10-4, Fisher’s exact test).  The collapsed minor allele frequency 
(cMAF) for all rare variants in FBN1 was 0.044 in cases (N=91), compared to 0.005 in controls 
(N=337) (OR=10.4, 95% CI=2.7-39.5).  This result was surprising, as mutations in FBN1 are 
associated with Marfan syndrome (MIM 154700), an autosomal dominant and highly penetrant 
disorder that causes skeletal, ocular and cardiovascular phenotypes.  Likely a result of the small 
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sample size, the association did not reach exome-wide significance (P<2.5×10-6).  However, 
FBN1 was a compelling candidate for AIS because 63% of Marfan syndrome patients develop 
scoliosis [13].  Congenital contractural arachnodactyly (MIM 121050) is a related disorder that 
has large phenotypic overlap with Marfan syndrome, including scoliosis which develops in 50% 
of patients [14], and is caused by autosomal dominant mutations in fibrillin-2 (FBN2).  FBN2 
showed weak association with AIS in our exome sequencing screen (cMAF=0.022) compared to 
controls (cMAF=0.004) (P=0.0404, Fisher’s exact test), but was also a compelling candidate for 
AIS due to a recent genome-wide association study that identified an FBN2 single nucleotide 
polymorphism (SNP) among the top 100 SNPs associated with AIS [15]. 
 
Rare coding variants in FBN1 and FBN2 are enriched in severe AIS 
Based on the results of our exome sequencing screen, FBN1 and FBN2 were selected as 
candidate genes to study in a larger cohort.  Both genes were sequenced in additional AIS 
patients and controls using a newly described targeted capture approach.  In total, 323 severely 
affected AIS cases and 493 controls of European descent were analyzed for rare variants in 
FBN1 or FBN2.  All cases and controls had ≥95% coverage at ≥8X read depth to be included in 
the gene analysis.  The average spinal curve in the AIS cohort was 57.4° (SD=12.1°).  As an 
independent control cohort, we also identified rare variants in FBN1 and FBN2 for 4,300 
individuals of European ancestry from the NHLBI GO Exome Sequencing Project (ESP) 
controls (N=4,300).  
For FBN1, rare variants were enriched in AIS cases (cMAF=0.021) compared to both in-
house controls (cMAF=0.005) (P=0.0041, Fisher’s exact test) and ESP controls (cMAF=0.005) 
(P=8.14×10-5, Fisher’s exact test) (Table 3.1).  Thirteen AIS patients (4.2%, N=13/311) and five 
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in-house controls (1.0%, N=5/489) were identified with a rare variant in FBN1.  An estimated 
1.0% (N=44/4300) of ESP controls had a rare FBN1 variant (assuming each individual harbored 
only one variant).  All AIS variants were heterozygous and caused missense amino acid changes 
throughout the FBN1 protein (Figure 3.1A, Table 3.2).  Segregation was evaluated for nine families 
where DNA was available from one or more additional family members (Figure 3.2).  Variants segregated 
with AIS in some families.  Two variants (p.G1217S and p.G1313S) were located in the neonatal 
region of FBN1 (exons 24-32), which is typically associated with a more severe, early-onset 
form of Marfan syndrome [16,17].  Three variants were previously reported in Marfan syndrome 
(p.L1405R [18],  p.M1576T [19,20] and p.I2585T [18,21,22]) and one of these variants 
(p.M1576T) was recurrent in three AIS patients (Table 3.2).  Variants previously reported in 
Marfan syndrome were also identified in the ESP cohort (p.D1479E [18], p.E2019K [23], 
p.R2554W [24], p.R2694Q [25] and p.S2832G [25]) whereas none of the in-house control 
variants were previously reported as pathogenic.   
  Similarly, rare FBN2 variants were also enriched in AIS cases (cMAF=0.017) compared 
to in-house controls (cMAF=0.006) (P=0.0307, Fisher’s exact test) and ESP controls 
(cMAF=0.007) (P=0.0054, Fisher’s exact test) (Table 3.1).  Eleven AIS patients (3.5%, 
N=11/316), five in-house controls (1.2%, N=5/427) and approximately 1.3% (N=56/4300) of 
ESP controls were identified with a variant in FBN2.  All AIS variants were heterozygous and 
caused missense mutations, except for a five base insertion present in one AIS case (Figure 3.1B, 
Table 3.2).  DNA was available for one or more additional family members in seven families.  Variants 
segregated in some families (Figure 3.2).  In congenital contractural arachnodactyly, pathogenic 
mutations are limited to the neonatal region (exons 23-34) [26].  In contrast, variants identified in 
AIS patients were located throughout the protein, including the neonatal region (p.R1021C, 
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p.I1116S, p.L1125V and p.G1271A).  None of the variants identified in AIS cases or controls 
were previously reported in congenital contractural arachnodactyly.  
Combining rare variants from both FBN1 and FBN2 yielded a cMAF of 0.039 in AIS 
cases, 0.012 in controls (P=5.46×10-4, Fisher’s exact test) and 0.012 in ESP controls (P=1.48×10-
6, Fisher’s exact test) (Table 3.1).  Only one AIS case and none of the in-house controls had a 
variant in both FBN1 and FBN2.  Thus, variants in either FBN1 or FBN2 were identified in 7.6% 
(N=23/304) of AIS cases, 2.4% (N=10/425) of in-house controls and approximately 2.3% 
(N=100/4300) of ESP controls. 
In addition to AIS cases with severe scoliosis, we also sequenced 112 AIS cases of 
European ancestry with mild to moderate scoliosis (curve <40°).  The average spinal curve in 
this cohort was 28.1° (SD=6.9°).  Rare variants in FBN1 and FBN2 were identified in 1.9% 
(N=2/106) and 0.9% (N=1/107), respectively, of the mild to moderately affected AIS cases 
(Figure 3.1A, Figure 3.1B, Table 3.2).  FBN1 and FBN2 rare variant frequencies were not 
significantly different in mild to moderate AIS cases compared to in-house controls (P=0.47, 
Fisher’s exact test) or ESP controls (P=0.42, Fisher’s exact test). 
 
Distinct clinical features of AIS patients with rare fibrillin variants 
To determine if AIS patients with rare fibrillin variants manifest unique clinical 
characteristics, we compared patients with variants in FBN1 (N=15) and FBN2 (N=12) to 
patients without rare variants in either gene (N=379) (Table 3.3).  Analysis was limited to 
individuals of European ancestry, but included all curve severities (≥10°).  The average spinal 
curve was 20° greater in AIS patients with an FBN1 variant compared to other patients 
(P=6.91×10-4, Mann-Whitney-Wilcoxon test).  All 15 AIS patients with rare FBN1 variants 
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developed scoliosis with a Cobb angle of ≥35° (Table 3.2), which would typically warrant 
bracing or surgery.  FBN1 variants were also associated with taller stature standardized to age 
and gender (P=0.0035, Mann-Whitney-Wilcoxon test).  Of all AIS patients in this cohort with 
height ≥90th percentile, 22.5% (N=9/40) were found to have a rare FBN1 variant.  Rare FBN1 
variants were also associated with Marfan-associated features, which were quantified using the 
revised Ghent criteria [4] (P=0.0072, Mann-Whitney-Wilcoxon test).  Gender, weight, body 
mass index, family history of treated AIS and joint hypermobility were not associated with the 
presence of rare FBN1 variants.  There were no unique clinical characteristics in AIS patients 
with rare FBN2 variants (Table 3.3).  However, like FBN1, we noted a trend towards greater 
spinal curves in AIS patients with FBN2 variants (P=0.10).   
 
Curve severity is associated with rare fibrillin variants in AIS cases of European and Han 
Chinese ancestry  
AIS patients of European ancestry with a rare variant in either FBN1 or FBN2 (N=26) 
developed an average spinal curve of 64.0°, compared to 49.0° in cases with no rare variants 
(N=364) (P=0.0012, Mann-Whitney-Wilcoxon test) (Figure 3.3).  Because predicting curve 
severity has important clinical implications, we performed a replication study in 370 Han 
Chinese AIS patients.  Our replication cohort included all curve severities ≥10° (average=34.1°, 
SD=12.5°).  Twenty-eight (7.6%, N=28/370) Han Chinese cases were identified with a rare 
coding variant in FBN1 or FBN2.  The average spinal curve in these cases (37.2°, N=28) was 
greater than cases with no rare variant in FBN1 or FBN2 (33.9°, N=342) (P=0.0376, Mann-
Whitney-Wilcoxon test) (Figure 3.3).  Moreover, 11.9% (N=12/101) of Han Chinese cases with 
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severe spinal curves measuring ≥40° had a rare variant in FBN1 or FBN2, compared to only 
5.9% (N=16/269) of cases with spinal curves <40° (P=0.04826, Fisher’s exact test). 
AIS cases of other ancestral background (N=47) were also sequenced in this study and an 
additional five rare variants in FBN1 and FBN2 were identified (Figure 3.1A, Figure 3.1B, Table 
3.2).  In all ancestries, the average spinal curve in AIS cases with a rare FBN1 or FBN2 variant 
was 50.5° (N=59), compared to 42.1° in cases with no fibrillin variant (N=742) (P=0.0026, 
Mann-Whitney-Wilcoxon test) (Figure 3.3). 
 
Evaluation of Marfan syndrome in AIS patients with FBN1 variants 
Pathogenic mutations in Marfan syndrome result in progressive dilation of the aorta, 
which predisposes individuals to aortic aneurysms and dissections [4].  Because the life-
threatening cardiovascular complications of Marfan syndrome are preventable, it is currently 
recommended that known or expected pathogenic mutations identified incidentally during 
clinical sequencing are reported [27].  Therefore, AIS patients with rare FBN1 variants were 
referred for additional evaluations assessing potential Marfan syndrome.  Nine patients agreed to 
additional evaluations and were subsequently assessed by a clinical geneticist (Table 3.4).  Three 
AIS patients had Marfan syndrome-associated mutations (p.L1405R, p.M1576T and p.I2585T) 
and six patients had variants of unknown significance (p.N280T, p.Q697R, p.N703H, p.N2178K, 
p.Y2225F and p.V2868I).  The revised Ghent nosology [4] was employed.  AIS patients were 
between 10 and 24 years old at time of evaluation.  Seven patients had imaging studies for aortic 
root dilation and five patients received a dilated eye exam.  Two AIS patients received physical 
examinations but no cardiac imaging studies.  Familial DNA was available for genotyping in nine 
families.  The FBN1 variant was inherited in eight families and one family was inconclusive (Figure 3.2).  
None of the AIS patients reported significant features suggestive of Marfan syndrome (ectopia lentis, 
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unexplained death, aortic dissection or aortic aneurysm) in any family members.  Nonspecific features of 
Marfan syndrome (e.g. pectus deformity, hypermobility) were present in some family members.  Only 
one of the nine patients that received additional evaluation met the diagnostic criteria for Marfan 
syndrome.  This patient (6386001) had aortic root dilation (Z-score=2.6) and significant Marfan-
associated systemic features (Ghent systemic features score=10) (Table 3.4).  Of all patients of 
European descent evaluated for systemic features (N=118), 6386001 was the only patient that 
scored ≥7, which is considered clinically significant [4].  The mutation identified in 6386001 
(p.I2585T) was previously described in multiple individuals with Marfan syndrome [18,21,22].   
 
Increased pSMAD2 in paraspinous muscle of AIS patients with rare FBN1 variants 
 Previous studies have shown that pathogenic FBN1 mutations causing Marfan syndrome 
result in upregulated transforming growth factor beta (TGF-β) signaling that can be measured in 
plasma or indirectly measured through activation of downstream targets, such as phosphorylation 
of SMAD2 (pSMAD2) [28-31].  To determine if AIS patients with rare FBN1 and FBN2 variants 
also have upregulated TGF-β, we used western blotting to examine pSMAD2 levels in 
paraspinous muscle from three AIS cases harboring a variant in FBN1 (p.P1225L, p.M1576T and 
p.G2003R) and one AIS case with a rare variant in FBN2 (p.P740H) (Figure 3.4).  Paraspinous 
muscle was also collected for a patient diagnosed with Marfan syndrome (positive control) and 
an unaffected individual who did not have scoliosis (negative control).  Compared to the 
unaffected control, pSMAD2 was elevated in all AIS patients with rare FBN1 variants and in the 
Marfan syndrome patient.  We observed similar pSMAD2 levels the AIS patient with a rare 
FBN2 variant compared to the unaffected control.   
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DISCUSSION 
 
Pathogenic mutations in FBN1 are most frequently associated with Marfan syndrome 
[32] where over 1,000 mutations have been described [33], but mutations in FBN1 have also 
been reported in ectopia lentis syndrome [34], isolated aortic aneurysm [35-38], Shprintzen-
Goldberg syndrome [39], Weill-Marchesani syndrome [40], geleophysic and acromicric 
dysplasia [41], stiff skin syndrome [42] and MASS phenotype (myopia, mitral valve prolapse, 
borderline aortic root dilation, skeletal and skin findings) [43].  Mutations in FBN2 have 
previously been associated only with congenital contractural arachnodactyly [44].  In the current 
study, we demonstrate an important role for FBN1 and FBN2 in the pathogenesis of AIS, 
broadening the spectrum of fibrillin-related disorders.   
Until now, the majority of FBN1 and FBN2 sequencing studies have been limited to 
select cohorts of patients with suspected Marfan syndrome and congenital contractural 
arachnodactyly, particularly because the cost of sequencing FBN1 and FBN2, each consisting of 
~11kb of coding sequence spread over 65 exons, is prohibitively high in large cohorts.  However, 
FBN1 mutations were previously described in a family with isolated kyphoscoliosis [45] and a 
family with isolated skeletal features including scoliosis [46] suggesting that fibrillin might 
contribute to isolated skeletal phenotypes, like AIS.  In addition, earlier investigations revealed 
fibrillin abnormalities in the fibroblasts of AIS patients [47], but linkage analysis did not support 
segregation of the FBN1 locus in large AIS pedigrees [48] and further genetic studies in AIS 
were not pursued. 
Using exome sequencing and a cost-effective targeted capture approach to sequence 
FBN1 and FBN2, we found that the burden of FBN1 and FBN2 rare variants is relatively high in 
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severely affected AIS patients, with 7.6% of patients of European ancestry having a rare variant 
in either gene, over three-times the frequency of controls (2.4%).  Curve severity was the most 
striking clinical finding that distinguished patients with rare fibrillin variants, leading to spinal 
curves that were on average 15° larger than observed in other AIS patients.  Interestingly, 
scoliosis is common in patients with Marfan syndrome [13] and congenital contractural 
arachnodactyly [14] and, like the AIS cases studied here, often progresses to severe curves 
[49,50].  Our findings indicate that FBN1 and FBN2 variants could serve as prognostic genetic 
markers to predict scoliosis progression.  This has important clinical utility because of the 
potential to develop personalized prevention strategies for those at high risk of severe deformity 
and to eliminate screening and treatment for patients at low risk [51-53].   
In addition to spinal curve progression, we found that rare FBN1 variants are also 
associated with tall stature in the AIS population.  Because nearly one-quarter of AIS cases in 
our study with height ≥90th percentile had a rare FBN1 variant, this easily obtainable clinical 
measure can identify patients who are particularly likely to harbor these genetic variants and may 
benefit from FBN1 sequencing studies.  We also found that AIS patients with FBN1 variants 
collectively scored higher using the Ghent systemic features scoring system [4], which evaluates 
several nonspecific physical traits that are common in Marfan syndrome.  However, the 
differences were small and the systemic features score is unlikely to be useful for identifying 
individual AIS patients with rare FBN1 variants.  Despite this, our data confirm that the systemic 
features scores do have utility as a screen for unrecognized Marfan syndrome in the AIS 
population, as the only patient with a clinically significant systemic feature score (≥7) was 
identified with an FBN1 mutation and subsequently diagnosed with Marfan syndrome as a part 
of this study after additional clinical testing.  
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While FBN1 mutations causing Marfan syndrome are associated with life threatening 
cardiovascular complications, our data suggest that the majority of AIS-associated variants are 
associated with a more benign course.  First, physical findings were not suggestive of Marfan 
syndrome in most patients (N=8/9) and, had these patients been evaluated without knowledge of 
FBN1 mutation status, Marfan syndrome would not have been suspected and FBN1 testing 
would not have been recommended based on clinical genetics evaluations alone.  Second, the 
majority of patients who received imaging studies of the aorta showed no evidence of aortic 
dilation (N=6/7), which is the cardinal feature of Marfan syndrome.  Third, family histories did 
not endorse Marfan syndrome.  Rare FBN1 variants were inherited from a parent in at least seven 
families, but no patient reported family members with features suggestive of Marfan syndrome, 
including aortic dilation, aortic aneurysm or dissection, ectopia lentis, or unexplained death.  
However, despite little evidence supporting a diagnosis of Marfan syndrome in most AIS 
patients with rare FBN1 variants, one AIS patient not previously suspected of the disorder was 
diagnosed as a direct result of this study.  Because there are treatments available to prevent the 
life-threatening aortic complications of Marfan syndrome (e.g. losartan [28,54-56]), recognition 
of the disorder can significantly affect patient outcomes.  Unfortunately, for AIS patients with 
FBN1 variants who did not fulfill the diagnostic criteria at the time of examination, the absence 
of aortic dilation does not conclusively rule out Marfan syndrome and aortic dilation may 
develop later in life [4].  Ongoing screening of all AIS patients with rare FBN1 variants is 
therefore warranted and is consistent with the current recommendations for patients with FBN1 
mutations who do not fulfill diagnostic criteria [23,57].  Regardless of the long-term risks 
associated with rare FBN1 variants, FBN1 sequencing in the AIS population is likely to have 
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clinical value, either as an early indicator of potential Marfan syndrome or as a predictor of 
progressive AIS.   
Congenital contractural arachnodactyly does not appear to be associated with the same 
risk of life-threatening cardiovascular complications as Marfan syndrome; however, aortic 
dilation has been described in several patients and echocardiographic evaluations are currently 
recommended [26].  AIS patients with rare FBN2 variants did not receive additional clinical 
evaluation, but patient histories did not indicate “crumpled” ears, muscular hypoplasia, 
contractures of the major joints or other features that would be suggestive of congenital 
contractural arachnodactyly.   
Although our findings suggest that rare variants in FBN1 and FBN2 are associated with 
AIS rather than unrecognized Marfan syndrome or congenital contractural arachnodactyly, 
additional long-term studies of AIS patients with fibrillin abnormalities are needed.  Such studies 
would clarify the potential future complications, if any, associated with rare fibrillin variants and 
inform the interpretation of incidentally identified FBN1 and FBN2 variants in future diagnostic 
or research studies. 
FBN1 and FBN2 are expressed with significantly overlapping patterns beginning during 
early development (see review [58]) and the biological mechanism leading to scoliosis when 
FBN1 and FBN2 are mutated remains unclear, even in cases of Marfan syndrome and congenital 
contractural arachnodactyly.  Aberrant activation of the TGF-β pathway has been observed in 
Marfan syndrome [30] and may be responsible for some of the skeletal features, like tall stature 
[59].  We found that AIS patients with FBN1 variants were also tall, which suggests that these 
protein changes also alter TGF-β signaling.  We showed upregulation of the TGF-β pathway in 
paraspinous muscle of three AIS patients with rare FBN1 variants, confirming that at least some 
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of the variants identified in AIS have functional effects.  Recent studies have shown that FBN2 
also regulates TGF-β signaling [60], but we did not observe upregulation of TGF-β in muscle 
from an AIS patient with a rare FBN2 variant, suggesting that the variant may not have an effect 
on this aspect of FBN2 function.  Unfortunately, we did not have access to muscle on a larger 
cohort of AIS patients and further studies will be required to demonstrate more definitively that 
these gene variants activate the TGF-β pathway.  Interestingly, the TGF-β pathway is also 
upregulated in patients with Loeys-Dietz syndrome [61,62], a disorder that has many overlapping 
features with Marfan syndrome and congenital arachnodactyly and is highly associated with 
scoliosis [63].  Because scoliosis is a common feature of several Mendelian disorders involving 
the TGF-β signaling pathway, other genes in the TGF-β pathway may be good candidates for 
AIS, which is supported by a recent study that identified transforming growth factor beta-1 as a 
novel susceptibility gene for AIS [64].   Moreover, an association of TGF-β signaling with AIS 
could explain why other Marfan-associated features are observed more frequently in AIS patients 
than in the general population, including tall stature [65], joint hypermobility [66], pectus 
excavatum [67,68] and dural ectasia [69],  Recent studies in mouse models and humans with 
Marfan syndrome have shown promising developments in therapeutic strategies to reduce the 
hyper-activated TGF-β pathway, including TGF-β neutralizing antibody and the angiotensin II 
type 1 receptor blocker, losartan [28,54-56].  The potential link between AIS and the TGF-β 
signaling pathway suggests the possibility that drugs like losartan may someday be useful to treat 
AIS cases in which the TGF-β pathway is activated. 
In summary, we demonstrate an important role for FBN1 and FBN2 in AIS pathogenesis.  
We show that rare variants are enriched in severely affected AIS patients and are significantly 
associated with curve severity.  Because reliable methods for predicting scoliosis progression are 
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not currently available, these results have immediate clinical utility.  Furthermore, we show 
altered TGF-β signaling in AIS patients with fibrillin mutations, which opens up the possibility 
of novel treatments that have not previously been considered for AIS.  
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Figure 3.1: Rare FBN1 and FBN2 variants identified in AIS patients 
Protein structure of FBN1 and FBN2 (redrawn [70]).  (A) Missense variants were identified 
throughout FBN1 in AIS patients of European descent (N=417) and other ancestries (N=47).  
Variants previously associated with Marfan syndrome are in bold.  (B) Missense and other 
coding changes were identified in FBN2 in AIS patients of European (N=423) and other 
ancestries (N=47).  Asterisk indicates variants identified in other ancestries. 
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Figure 3.2: Segregation of FBN1 and FBN2 variants  
Variant segregation was evaluated for AIS families with two or more individuals available for 
genotyping.  The presence of AIS resulting in bracing or surgery (treated AIS), AIS that 
measured <20° or was self-reported and not treated (mild AIS) and other features of Marfan 
syndrome and congenital contractural arachnodactyly (pectus carinatum, pectus excavatum, 
hypermobility, spondylolisthesis) are shown.    
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Figure 3.3: Rare FBN1 and FBN2 variants are associated with curve severity in AIS   
The average spinal curve was determined for AIS cases with a rare variant in either FBN1 or 
FBN2 (Variant) and AIS cases without a rare variant in either gene (No variant).  AIS cases of 
European ancestry (N=405), Han Chinese ancestry (N=370) and a combined analysis consisting 
of cases of European, Han Chinese and other ancestries (N=801) consistently showed that 
patients with rare variants in FBN1 or FBN2 developed larger spinal curves.  Asterisk indicates 
the following P-values: *<0.05, **<0.01. 
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Figure 3.4: Elevated pSMAD2 in AIS patients with rare FBN1 variants   
Paraspinous muscle from an unaffected control, AIS cases with rare variants in FBN1 or FBN2 
and a Marfan syndrome patient were immunostained for pSMAD2.  pSMAD2 was elevated in 
AIS cases with rare FBN1 variants at levels similar to Marfan syndrome.  pSMAD2/actin ratio is  
shown normalized to the unaffected control.
 
 
Table 3.1: Rare variant frequencies for FBN1 and FBN2 in AIS cases and controls of European ancestry 
 
 AIS cases (≥40°) Controls (this study) Controls (ESP) 
 N Variant alleles cMAF N 
Variant 
alleles cMAF 
Odds ratio 
(95% CI) P-value N 
Variant 
alleles cMAF 
Odds ratio 
(95% CI) P-value 
FBN1 311 13 0.021 489 5 0.005 4.2 (1.5-11.7) P=0.0041 4,300 44 0.005 4.2 (2.2-7.7) P=8.14×10-5 
FBN2 316 11 0.017 427 5 0.006 3.0 (1.0-8.7) P=0.0307 4,300 56 0.007 2.7 (1.4-5.2) P=0.0054 
FBN 
or  
FBN2 
304 24 0.039 425 10 0.012 3.5 (1.6-7.3) P=5.46×10-4 4,300 100 0.012 3.5 (2.2-5.5) P=1.48×10-6 
cMAF, collapsed minor allele frequency; ESP, NHLBI Exome Sequencing Project 
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Table 3.2: Rare FBN1 and FBN2 variants identified in AIS cases (curve ≥10°) 
Case Scoliosis curve Ancestry 
Genomic  
position (hg19) Base change Gene 
GVS 
function 
Amino acid 
change 
ESP 
frequencya 
Disease 
association 
6128001 84° EUR chr15:48902952 T>A FBN1 missense p.Ile107Leu - - 
6340001 48° EUR chr15:48826300 T>G FBN1 missense p.Asn280Thr - - 
6390001 60° AFR chr15:48796007 T>C FBN1 missense p.Gln697Arg - - 
6377001 50° EUR chr15:48795990 T>G FBN1 missense p.Asn703His - - 
6016001 36° Other chr15:48784766 C>T FBN1 missense p.Val916Met N=1/6,494 - 
1044 70° EUR chr15:48777634* C>T FBN1 missense p.Gly1217Ser - - 
6273001 48° AFR chr15:48777609* G>A FBN1 missense p.Pro1225Leu - - 
1083 52° EUR chr15:48773879* C>T FBN1 missense p.Gly1313Ser - - 
6226001 97° EUR chr15:48764870 A>C FBN1 missense p.Leu1405Arg - MFS [18] 
6272001 90° EUR 
chr15:48760155 A>G FBN1 missense p.Met1576Thr - MFS [19,20] 6418001 65° EUR 
6442001 35° EUR 
450-14600 38° EUR chr15:48741087 C>T FBN1 missense p.Arg1850His - - 
6320001 66° EUR chr15:48736768 C>T FBN1 missense p.Gly2003Arg - - 
6368001 100° EUR chr15:48726873 A>T FBN1 missense p.Asn2178Lys - - 
6111001 95° EUR chr15:48725128 T>A FBN1 missense p.Tyr2225Phe - - 
6386001 93° EUR chr15:48712949 A>G FBN1 missense p.Ile2585Thr - MFS [18,21,22] 
6005001 55° EUR chr15:48703201 C>T FBN1 missense p.Val2868Ile - - 
6463001 57° AFR chr5:127873139 C>T FBN2 missense p.Gly53Asp N=2/6,489 - 
6112001 48° EUR chr5:127872157 C>T FBN2 missense p.Arg92Lys - - 
1157 45° EUR chr5:127782238 A>ACTGTA FBN2 frameshift - - - 
6124001 75° EUR chr5:127713520 C>T FBN2 missense p.Val592Met - - 
6279001 55° EUR chr5:127704904 G>T FBN2 missense p.Pro740His - - 
1022 25° EUR chr5:127681205* G>A FBN2 missense p.Arg1021Cys - - 
6191001 90° EUR chr5:127674750* A>C FBN2 missense p.Ile1116Ser - - 
6129001 80° EUR chr5:127674724* G>C FBN2 missense p.Leu1125Val - - 
6367001 70° Other chr5:127673755* C>T FBN2 missense p.Glu1178Lys - - 
6229001 65° EUR chr5:127671182* C>G FBN2 missense p.Gly1271Ala - - 
6206001 50° EUR chr5:127627260 G>T FBN2 missense p.Pro2085Thr - - 
6383001 43° EUR chr5:127613647 T>C FBN2 missense p.Ile2466Val N=1/6,503 - 
6418001 65° EUR chr5:127609564 A>G FBN2 missense p.Phe2603Ser N=2/6,503 - 
6216001 50° EUR chr5:127607792 C>T FBN2 missense p.Gly2620Glu - - 
NA, not available; EUR, European; AFR, African; ESP, NHLBI Exome Sequencing Project; MFS, Marfan syndrome 
*Neonatal region 
aFrequency includes individuals of African and European ancestry 
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Table 3.3: Clinical characteristics of AIS cases (curve ≥10°) of European ancestry with rare 
variants in FBN1 and FBN2 
  No variant FBN1  P-value FBN2  P-value 
Female 86%  (N=379) 
80% 
(N=15) P=0.35 
83% 
(N=12) P=0.51 
Spinal curve  
(avg ± sd) 
49° ± 16 
(N=364) 
69° ± 23 
(N=15) P=6.91×10
-4 58° ± 18 (N=12) P=0.10 
Height percentile  
(avg ± sd) 
55th ± 30 
(N=217) 
75th ± 31 
(N=15) P=0.0035 
56th ± 35 
(N=12) P=0.41 
Weight percentile  
(avg ± sd) 
57th ± 31 
(N=217) 
69th ± 30 
(N=15) P=0.06 
50th ± 33 
(N=12) P=0.25 
Body mass index 
(avg ± sd) 
22.2 ± 5.1 
(N=217) 
21.6 ± 4.0 
(N=15) P=0.42 
20.2 ± 3.6 
(N=12) P=0.06 
First degree relative with 
treated AIS 
16% 
(N=277) 
33%  
(N=12) P=0.12 
20% 
(N=10) P=0.50 
Beighton joint 
hypermobility score [5]  
(avg ± sd) 
1.4 ± 1.6 
(N=105) 
2.5 ± 2.8 
(N=10) P=0.09 
1.0 ± 0.8 
(N=4) P=0.45 
Ghent systemic features 
score [4] (avg ± sd) 
2.4 ± 1.4 
(N=105) 
4.2 ± 2.6 
(N=10) P=0.0072 
3.5 ± 1.9 
(N=4) P=0.10 
avg, average; sd, standard deviation    
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Table 3.4: Clinical features of AIS patients evaluated for Marfan syndrome 
G
en
er
al
 p
at
ie
nt
 in
fo
rm
at
io
n 
Case 6340001 6390001 6377001 6226001 6418001 6368001 6111001 6386001 6005001 
Ancestry EUR AFR EUR EUR EUR EUR EUR EUR EUR 
Gender M F F F F F M F F 
Age (years) 13 14 17 18 14 10 13 15 24 
Height (percentile) >99th 70th 57th 91st >99th >99th 93rd 98th 91st 
Weight (percentile) 99th 96th 62nd 85th 87th 88th 86th 92nd 95th 
Spinal curve 48° 60° 50° 97° 65° 100° 95° 93° 55° 
Curve type R-T R-T R-TC R-T R-T R-T L-T R-T R-T 
Treatment none surgery surgery surgery surgery surgery surgery surgery surgery 
FB
N
1 FBN1 variant p.N280T p.Q697R p.N703H p.L1405R p.M1576T p.N2178K p.Y2225F p.I2585T p.V2868I 
Variant reported in MFS No No No Yes Yes No No Yes No 
M
ar
fa
n 
sy
nd
ro
m
e 
ev
al
ua
tio
n 
MFS diagnosis No No No No No No No Yes No 
Aortic root dilation - NA NA - - - - + - 
Ectopia lentis - NA NA NA - NA - - - 
Systemic features score 3/22 3/17 1/17 2/20 4/18 2/22 5/18 10/22 6/18 
Pectus deformity - - - - - - - - - 
Hindfoot deformity - - - - - - - + + 
Pes planus - + - - + - + + + 
Wrist/thumb sign - - - - - - - + - 
Upper/Lower segment 1.17 0.93 0.97 1.00 0.95 0.88 0.85 0.76 0.99 
Arm span/Height 1.03 1.08 0.98 1.01 1.01 1.03 1.07 1.09 1.02 
Reduced elbow extension - - - - + - - - - 
Dural ectasia - NA NA - NA - NA - NA 
Protrusio acetabuli - NA NA NA NA - NA - NA 
Skin striae + + - + + - + + + 
Facial features (3/5) - - - - - - - - - 
Myopia + - - - - - + + + 
Pneumothorax - - - - - - - - - 
Mitral valve prolapse - NA NA - - - - - - 
H
yp
er
m
ob
ili
ty
 e
va
lu
at
io
n 
Hypermobility score 0/9 0/9 1/8 4/8 1/9 2/9 2/8 2/9 9/9 
Hands flat on floor - - - NA - - - - + 
L knee overextends - - - - - - + - + 
R knee overextends - - - - - - + - + 
L elbow bends >10° - - - - - - - - + 
R elbow bends >10° - - - - - - - - + 
L thumb touching 
forearm - - + + - + - + + 
R thumb touching 
forearm - - NA + + + NA + + 
L little finger >90° - - - + - - - - + 
R little finger >90° - - - + - - - - + 
+, present; -, absent; L= left; R= right; T= thoracic; TC= thoracolumbar; EUR, European; AFR, African;  MFS, Marfan syndrome; NA= not available 
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Chapter 4: 
Kinesin Family Member 6 (kif6) is Necessary for Normal  
Vertebral Development in Zebrafish 
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SUMMARY 
 
Idiopathic scoliosis is a common condition in humans that causes spinal deformity in 2-
3% of the at risk population.  The pathogenesis of idiopathic scoliosis remains poorly 
understood, in part due to the lack of a relevant animal model. To identify a zebrafish model for 
idiopathic scoliosis, we performed a forward mutagenesis screen and identified skolios, a 
recessive zebrafish mutant with a spinal curvature phenotype. skolios develops an isolated spinal 
deformity phenotype that parallels certain features of human idiopathic scoliosis, including a 
medial-lateral curvature of the spine that arises independent of vertebral malformations.  To 
identify the genetic basis of skolios, we used meiotic mapping to narrow the locus to a 2.7 Mb 
region on chromosome 17.  Low-coverage whole genome sequencing was then used to identify 
candidate mutations within the mapped locus.  Twenty homozygous nonsynonymous mutations 
were identified in the locus.  Only one nonsynonymous change resulted in a nonsense mutation, 
which caused a premature stop in kinesin family member 6 (kif6), a poorly characterized kinesin 
of unknown function.  To confirm that loss of kif6 is responsible for the skolios phenotype, we 
created additional mutant alleles using transcription activator-like effector nucleases (TALENs).  
Three new TALEN-induced mutations causing frameshift mutations in kif6 were identified.  All 
zebrafish homozygous or compound heterozygous for kif6 frameshift mutations developed a 
scoliosis phenotype that was indistinguishable from skolios mutants, confirming kif6 as the 
causative gene.  Although kif6 may play a role in cilia, no evidence for cilia dysfunction was 
seen in skolios mutants.  Overall, these findings demonstrate a novel role for kif6 in the 
developing spine and identify a new candidate gene for human idiopathic scoliosis. 
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INTRODUCTION 
 
Idiopathic scoliosis is a multifaceted genetic disorder that causes curvature of the spine in 
2-3% of humans, with about 10% of patients progressing to deformity warranting bracing or 
surgical treatment.  Although idiopathic scoliosis is defined by a deviation of the spine from the 
midline in the medial-lateral plane, curvature is typically complex and causes a three 
dimensional deformity affecting all three planes (medial-lateral, dorsal-ventral and transverse).  
Unlike secondary scoliosis that arises from congenital vertebral malformations or other 
syndromic conditions, idiopathic scoliosis is poorly understood and no obvious structural 
vertebral abnormalities are present.  A major challenge in determining the pathogenesis of 
idiopathic scoliosis has been the lack of a relevant animal model.  Animal models of idiopathic 
scoliosis have been primarily limited to experimental forms of scoliosis, where scoliosis is 
induced by invasive surgical procedures, immobilization or the use of the systemic agents [1].  
Because spinal deformity develops secondary to harsh interventions, experimentally induced 
forms of scoliosis are unlikely to recapitulate many features of human idiopathic scoliosis.   
With the exception of humans, naturally occurring scoliosis is relatively rare [2].  
Humans ambulate in an upright position with their center of gravity over the pelvis, a 
characteristic that is unique even among other primates [3].  This erect, bipedal posture 
significantly alters the dorsal shear loads of the spine, which has been proposed as an important 
prerequisite for scoliosis development [4].  In support of this model, pinealectomized rats 
develop scoliosis when also made bipedal, whereas similarly treated quadrupedal rats do not [5].  
Although pinealectomy and bipedalism may be important prerequisites for scoliosis in some 
species, pinealectomy in bipedal nonhuman primates does not cause spinal deformity [6].  
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Moreover, pinealectomy in guppy [7] and salmon [8] induces spinal curvature similar to bipedal 
rats, demonstrating that scoliosis induced by pinealectomy does not require bipedalism.   
A mutant guppy strain, curveback, is one of the few examples of an animal model with 
non-induced spinal deformity that parallels human idiopathic scoliosis [7].  curveback mutants 
develop a spinal curvature sporadically in the dorsal-ventral and medial-lateral plane that is not 
due to vertebral malformations.  Sporadic spinal deformity has also been noted in other teleosts, 
including medaka and swordtail, suggesting that teleosts may be ideal animal models to identify 
and characterize naturally occurring scoliosis [9].  Of the teleosts, zebrafish (Danio rerio) are 
particularly well-suited model organisms, as zebrafish are highly tractable and have extensive 
genomic resources.  Scoliosis in zebrafish has been largely unexplored.  The zebrafish mutant 
leviathan is caused by recessive mutations in collagen type VIII alpha1a (col8a1a) and develops 
scoliosis, although mutants also develop notochord defects and congenital vertebral 
malformations [10].  It remains unclear if zebrafish are susceptible to naturally occurring 
scoliosis without vertebral malformations.  Therefore, we sought to identify novel zebrafish 
scoliosis mutants that could serve as a model for human idiopathic scoliosis.  Using an N-ethyl-
N-nitrosourea (ENU) mutagenesis forward genetic screen, we identify and describe skolios, a 
zebrafish mutant with recessively inherited scoliosis that shares several characteristics with 
human idiopathic scoliosis.  
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METHODS 
 
Zebrafish maintenance 
Zebrafish were maintained under standard conditions [11].  Zebrafish were bred by in 
vitro fertilization using adults anesthetized in 0.16% tricaine methanesulfonate (3-amino benzoic 
acidethylester, Sigma-Aldrich) diluted in E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 
mM CaCl2, MgSO4 in H20) or by natural pairwise mating.  With exception to WIK strains used 
for meiotic mapping, all wild-type (WT) zebrafish were from an AB genetic background.  
Experiments were carried out in accordance with the animal protocol guidelines at Washington 
University.  
 
Chemical Mutagenesis and Forward Genetic Screening 
skolios was identified from an ENU mutagenesis screen performed on WT (AB) 
zebrafish.  The generation of mutagenized F1 female fish was carried out with ENU as 
previously described [12].  Gynogenetic diploids were subsequently derived by the early 
pressure method [13] and screened for spinal curvature.  
 
Analysis of spinal and vertebral morphology 
 MicroCT imaging was performed using a VivaCt40 machine (ScanCo) as previously 
described [14].  Zebrafish observations were imaged using an Olympus DP70 Digital 
Microscope Camera fixed to an Olympus MVX10 MacroView fluorescence microscope with 
MicroSuite Basic Edition software (Olympus).  For bone and cartilage staining, zebrafish at 
various time points were euthanized with tricaine methanesulfonate and fixed in 4% PFA/PBS.  
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Fixed zebrafish were immersed in 0.1% alcian blue in 7:3 EtOH:glacial acetic acid for 24-
48 hours and destained for 0.5-2 hours in 7:3 EtOH/glacial acetic acid to visualize cartilage.  
Bones were then stained with alizarin red S in 0.5% KOH for 6-24 hours and destained in 0.5% 
KOH.  Stained zebrafish were stored in glycerol.  The spinal curvature was quantified by 
imaging zebrafish positioned laterally.  For consistency, spinal curvature was only quantified 
near the transition from abdominal (rib vertebrae) to caudal vertebrae (vertebrae posterior of 
ribs), which excluded the most anterior and posterior vertebrae.  The apex of the curve was 
identified within the defined region and lines were drawn through the center of the two vertebrae 
adjacent to the apex.  The angle of the two intersecting lines was measured using Photoshop CS3 
(Adobe).  Measured angles were subtracted from 180° to calculate the spinal curve.   
 
Meiotic mapping and whole genome sequencing 
 The skolios mutation was localized to chromosome 17 using centromeric linkage analysis 
[10,15].  Fine mapping was achieved by mapcrossing to the polymorphic WIK strain and 
assessing for recombination along chromosome 17 by sequence length polymorphism analysis 
[16].  For whole genome sequencing, genomic DNA from a skolios mutant was extracted using 
Proteinase K (Roche) and 25:24:1 phenol:chloroform:isoamyl (Roche) according to the 
manufacturer’s instructions.  Whole genome sequencing was performed by the Genome 
Technology Access Center at Washington University.  One lane of a HiSeq 2000 sequencer 
(Illumina) was used to generate 101 bp paired-end reads.  Raw sequencing reads were aligned to 
the Zv9 genome assembly using Novoalign (Novocraft Technologies).  Variants were identified 
using SAMtools software [17] and annotated using SnpEff software [18].  Variants were 
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validated by Sanger sequencing using an ABI 3730 Sequencer (Life Technologies) and 
visualized using Sequencher DNA Sequencing software (Gene Codes).    
 
RT-PCR of adult zebrafish tissues 
Tissue samples were harvested from adult zebrafish euthanized in tricaine 
methanesulfonate.  Tissue samples were dissected and pooled from 5-10 zebrafish and total RNA 
was extracted using Trizol Reagent (Invitrogen).  RNA concentrations were measured using a 
NanoDrop 2000 UV-Vis spectrophotometer.  cDNA synthesis was performed using SuperScript 
II Reverse Transcriptase (Invitrogen) with 1 µg RNA according to the manufacturer’s 
instructions.  As a negative control, cDNA synthesis reactions were also performed with the 
reverse transcriptase omitted.  PCR reactions were performed with Bullseye Taq Polymerase 
(Midsci) using 1 µl cDNA and 35-40 amplification cycles with 58° annealing temperature and 30 
second extension.  The following primers were used: 
kif6 (ex1-3) 5’- CGTGCAGGTAAACAGTAAAAGC -3’ 
   5’- CAGCAACAGGTTTTGCAATG -3’    
kif6 (ex16-18) 5’-GCGGAGAGAACACAGGAAAC-3’ 
   5’-GTGCTGTTGAGCAGGTTGTG-3’    
β-actin  5’-TACAATGAGCTCCGTGTTGC-3’ 
   5’-AAGGAAGGCTGGAAGAGAGC-3’ 
 
Microinjection of morpholinos 
 Morpholinos (MOs) were purchased from Gene Tools, LLC to transiently knock-down 
zebrafish kif6.  MOs were designed to target the translation start site (trans-block) and the 
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boundary between exon 1 and intron 1 (splice-block).  An additional MO targeting the 
translation start site but containing a 5 base mismatch served as a negative control (mismatch).  
The 3’ end of the splice-blocking and mismatch MOs were modified with a fluorescein tag.  The 
sequences of the MOs are as follows: 
trans-block 5’-TTGCTTTTACTGTTTACCTGCACGT-3’ 
splice-block 5’-ACAAAAGCAAAACACTCACCGAGGT-3’ 
mismatch  5’-TGCTTAACGATCTTAATCATCGCTT-3’ 
MOs were prepared at concentrations ranging from 0.05 mM to 3 mM and approximately 500 pl 
were injected in 1-4 cell stage embryos. 
 
Transcription activator-like effector nuclease (TALEN) design and assembly 
 Two TALENs (left and right) were designed to target the second exon of kif6.  These 
sites flanked a BccI restriction site that was used for mutation screening.  TALENs were 
generated using the Golden Gate method as previously described [19].  Plasmids were acquired 
from the Golden Gate TALEN and TAL Effector Kit (AddGene) and RVD repeat arrays were 
cloned into pCS2TAL3DD and pCS2TAL3RR (AddGene).  Plasmids were transformed into 
DH5α competent cells (Invitrogen) and isolated using the QIAprep Spin Miniprep Kit (Qiagen).   
The following sequence targets and RVD sites were used to generate kif6 TALENs: 
Left target DNA  TCCCTCTTATTGTTG 
Left RVD sequence NG HD HD HD NG HD NG NG NI NG NG NN NG NG NN  
Right target DNA  GCATCTCTGGGAACC 
Right RVD sequence NN NN NG NG HD HD HD NI NN NI NN NI NG NN HD 
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Injection of TALEN RNA in zebrafish embryos 
 Complete plasmids (containing the scaffold and RVD arrays) were linearized using XhoI 
and 5’-capped mRNA was generated by in vitro transcription using the mMESSAGE 
mMACHINE SP6 Transcription Kit (Life Technologies).  Capped mRNA was purified using the 
RNeasy Mini Kit (Qiagen).  Left and right TALENs were combined at equal concentrations.  
WT embryos were collected and 40-50 pg of pooled TALENs were injected into the yolk of 1-4 
cell stage embryos.  Injected embryos and progeny were screened for TALEN-induced mutations 
by digesting PCR amplified DNA with BccI (New England Biolabs).  The following primers 
were used for screening the BccI restriction site: 
BccI  5’TGCAATAAATGGAAACAAGAACC-3’ 
5’-TTCGCACATTTGTTCAGTGAC-3’ 
 
Evaluation of cilia and cilia-related phenotypes 
 Defects in left-right asymmetry were determined by visualizing the position of the heart 
in 30 hpf embryos.  Abnormal left-right asymmetry was classified as ambiguous when the heart 
was positioned at the midline and as situs inversus when the heart was positioned left of the 
midline when viewed ventrally (the right side of the embryo).   Otoliths were evaluated by 
visualizing zebrafish laterally between 48-72 hpf.  Immunofluorescence staining was performed 
as previously described [20] using embryos collected at 28 hours post-fertilization (hpf).  
Embryos were dechorionated in protease type XIV (Sigma) and fixed in 4% paraformaldehyde 
for immunostaining with anti-acetylated tubulin monoclonal antibody 6-11-B1 (Sigma).  Fluid 
flow in the central canal was measured as previously stated [21].  Live 48 hpf zebrafish were 
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anesthetized in tricaine methanesulfonate and imaged at various time points after injection of 5% 
tetramethylrhodamine conjugated to 70,000 molecular weight dextran into the brain ventricle. 
 
Statistical analysis 
A one-tailed Student’s t-test was used for all statistical analyses. 
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RESULTS 
 
Identification of skolios 
To identify zebrafish mutants with scoliosis, we performed an ENU mutagenesis screen 
on wild-type (WT) AB zebrafish.  From this screen, we identified a new zebrafish mutant, 
skolios, which develops recessively inherited curvature of the body axis.   
Body curvature first develops in skolios mutants during embryonic hatching stages (2-3 
days post-fertilization [dpf]), causing a ventral curvature of the body axis that is frequently 
limited to the distal end of the tail (Figure 4.1A).  This early curvature arises without observable 
defects in the notochord (e.g. kinking) and is incompletely penetrant with variable expressivity.  
Approximately 20% of skolios embryos appear normal at 3 dpf, while the majority exhibit either 
moderate (~70%) or severe (~10%) ventral body curvature (Figure 4.1A, Figure 4.1B).   
Unlike the incompletely penetrant ventral body curvature first seen during hatching 
stages, curvature in the medial-lateral plane becomes fully penetrant during early larval stages 
(4-5 dpf) and progresses through later larval and juvenile stages (5-89 dpf) (Figure 4.1C).  
Although there is large phenotypic variability in the appearance and severity of the curve, body 
curvature defects are easily observed in both the dorsal-ventral and medial-lateral planes of all 
adult skolios mutants (Figure 4.1D).  Despite the severity of the deformity, adult skolios mutants 
are both viable and fertile.  Heterozygous mutants exhibit no overt embryonic or post-embryonic 
phenotype. 
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Characterization of spinal curvature in skolios mutants 
We performed microCT imaging of a skolios mutant and WT zebrafish at 50 dpf to 
determine if vertebral abnormalities underlie the curved body axis in skolios.  Compared to WT, 
the skolios mutant developed a marked curvature of the abdominal and caudal spine in both the 
dorsal-ventral and medial-lateral planes (Figure 4.1E).  To evaluate the temporal onset of 
curvature and to screen for vertebral defects, we performed a two-staining protocol using alcian 
blue, a positively charged dye that is thought to react with the acidic mucopolysaccharides in 
cartilage, and alizarin red, a dye that binds to mineralized bone [22].  Vertebral morphology was 
evaluated during several developmental time points for WT and skolios mutants.  To track the 
progression of the spinal curve, curves were measured in the dorsal-ventral plane as shown in 
Figure 4.2A. Although human idiopathic scoliosis is measured in the medial-lateral plane, 
individual zebrafish vertebrae were more easily observed when viewed laterally, which allowed 
for more accurate curve measurements.  All curves were measured at the curve apex near the 
transition from abdominal to caudal vertebrae.  By two months post-fertilization (mpf), the 
average spinal curve was similar in both male and female skolios mutants (Figure 4.2B).  In 
males, spinal curvature was progressive and by 18 mpf, the average curve was 46° (SD=15.3°), 
compared to an average of 28° (SD=14.1°) at 2 mpf (P=0.043, Student’s t-test).  Although the 
curves were similar at 2 mpf, males developed more severe spinal curves than females at both 7 
mpf (36° versus 25°, P=0.042, Student’s t-test) and 18 mpf (46° versus 27°, P=0.037, Student’s 
t-test).  Female curves were stable and did not change between 2 and 18 mpf.  In contrast, curves 
measured in WT zebrafish were consistently small, although the spinal curves in males and 
females were highly variable.  WT zebrafish measured at 2 and 7 mpf had an average spinal 
curve of 5.3° (SD=6.7°, N=8) in males and 3.4° (SD=2.1°, N=9) in females (not shown).   
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Spinal curvature in skolios mutants occurred in the absence of vertebral fusions or 
malformations (Figure 4.2C).  Vertebral fusions and malformations were noted in approximately 
30% of all skolios mutants, which was comparable to frequencies observed in WT zebrafish 
(Figure 4.3).   
 
Meiotic mapping 
To localize the gene for skolios, we performed meiotic mapping and narrowed the locus 
to a 2-5 Mb region prior to whole genome sequencing.  Meiotic mapping localized the mutation 
to a region bounded by markers z8980 on one side and either z9692 or z24344 on the other 
(z9692 but not z24344 was polymorphic in one WIK fish used for a mapcross, while z24344 but 
not z9692 was polymorphic in a second WIK fish used for a mapcross) (Figure 4.4A).  The 
marker z24344 is not currently listed in Ensembl Zv9 but the sequence can be found in GenBank 
(G47401.1) and can subsequently be located in Zv9.  The smaller region, between z8980 and 
z9692, mapped the phenotype to a 2.7 Mb locus at chr17:47,500,198-50,216,501 (Zv9). 
 
Whole genome sequencing 
 Although mapping limited the region harboring the mutation responsible for skolios to a 
2.7Mb region on chromosome 17, approximately 20 genes remained within the locus.  To 
simultaneously investigate all genes within the interval, low-coverage whole genome sequencing 
was performed on a single skolios mutant.  Next generation sequencing reads were aligned to the 
Zv9 Tübingen reference genome (Table 4.1).  Nearly three-quarters of the reference genome was 
covered at ≥3X, which we deemed sufficient to identify a homozygous base change.  In the 
mapped interval, 18,941 total variants were identified.  To eliminate strain-specific 
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polymorphisms resulting from the alignment of skolios (generated on an AB background) to the 
Zv9 sequence (Tübingen), variants that were present in sequence data from an unrelated 
zebrafish with a similar genetic background (AB) were removed.  Only 20 of the remaining 
variants were homozygous and caused a nonsynonymous amino acid change.  Among these, a 
single nonsense mutation was identified, causing a premature stop in kif6 (encoding kinesin 
family member 6).  The G>T transversion at chr17:48958292 (Zv9) occurs in the second exon of 
kif6, which would result in a C>A change in the kif6 mRNA (kif6 is encoded on the minus 
strand) and produce premature stop early in the kif6 protein (Figure 4.4B).  This variant was 
validated in an independent skolios mutant using Sanger sequencing (Figure 4.4C).  
 
TALEN-induced mutations in kif6 
 Transient knock-down of kif6 with morpholinos targeting the translation start site or the 
first exon-intron boundary recapitulated the embryonic curvature defects (Figure 4.5); however, 
kif6 morphants developed into normal adults (not shown).  Because the transient nature of 
morpholinos limits our ability to assess adult phenotypes, we sought to generate stable germline 
mutations in kif6 using TALENs (transcription activator-like effector nucleases), which have 
been shown to effectively induce new mutations in zebrafish [23].  TALENs are engineered 
proteins that can be designed to target a specific DNA sequence and introduce double-stranded 
breaks that are repaired through the error-prone nonhomologous end-joining pathway, thus 
introducing mutations near the targeted sequence [24].    
We designed a TALEN pair targeting a region in the second exon of kif6, which flanked a 
BccI restriction site and was adjacent to the G>T transversion at chr17:48958292 (Zv9) 
identified in skolios (Figure 4.6A).  TALENs were combined at equal concentrations and 
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injected into 1-4 cell stage WT embryos.  PCR amplification and subsequent digestion with BccI 
showed that all embryos injected with TALENs had some degree of undigested product, 
indicating that the BccI restriction site was disrupted by an induced mutation (Figure 4.6B).  
Because the F0 (injected) zebrafish are mosaic, zebrafish were outcrossed with WT adults to 
create stable lines.  Three new mutations were identified in the F1 generation: two different 8 bp 
deletions and a 4 bp deletion (Figure 4.6C).  Sibling crosses generated F2 zebrafish that were 
either homozygous or compound heterozygous for TALEN-induced kif6 mutant alleles.  All 
combinations produced zebrafish with curvature of the body axis in both embryonic and adult 
stages that were indistinguishable from skolios, strongly supporting kif6 as the genetic cause of 
skolios (Figure 4.7). 
 
Characterization of kif6 in zebrafish 
We performed RT-PCR at various embryonic time points and adult tissues to determine 
kif6 expression in WT zebrafish (Figure 4.8).  In embryos, kif6 was expressed at low levels 
starting at 24 hpf, which were maintained through 120 hpf.  In adult tissues, kif6 was expressed 
at low levels in brain, intestine, ovary and testis.   
 
Assessment of cilia-related phenotypes in skolios 
The function of kif6 is unknown, but it has been predicted to be involved in 
cilia/flagellum assembly or function [20,25,26], particularly in ciliated ependymal cells [27].  
Several characteristic phenotypes are common in zebrafish with cilia defects (reviewed in 
[28,29]), including ventral curvature of the embryo, left-right asymmetry defects, kidney cysts, 
hydrocephalus and otolith abnormalities.  Because skolios mutants develop embryonic body 
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curvature, one of several cilia-related phenotypes, we wondered whether kif6 might be involved 
in ciliary assembly/function. To address this we assessed skolios mutants for additional 
ciliopathy-related phenotypes.  To determine if skolios mutants exhibit an increased incidence of 
left-right asymmetry defects, we evaluated the position of the heart in WT and skolios embryos 
at 30 hpf (Figure 4.9A).  Normal heart positioning was identified in 93.6% of WT embryos 
(N=94) and 91.9% of skolios embryos (N=91.9%), suggesting that skolios is not associated with 
an increased incidence of left-right asymmetry defects.  Similarly, otoliths were evaluated and 
WT (N=391) and skolios mutants (N=305) at 48-72 hpf and appeared normal in 98.5% and 
98.7%, respectively (Figure 4.9B).  Other easily observed phenotypes that are characteristic of 
cilia defects, such as hydrocephalus and kidney cysts, were never observed in skolios. 
To more closely examine cilia in skolios, we evaluated cilia structure and function in the 
central canal.  To evaluate gross ciliary structure, we employed whole-mount confocal 
immunostaining using an antibody labelling acetylated tubulin.  No gross abnormalities in ciliary 
number or morphology were detected in 28 hpf embryos compared to WT (Figure 4.9C).  To 
evaluate ciliary function, we assessed the movement of dye down the central canal in 48 hpf WT 
and skolios embryos using a previously described assay [21].  No differences in dye movement 
were observed in skolios mutants compared to WT (Figure 4.9D).   
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DISCUSSION 
 
Despite the high frequency of idiopathic scoliosis in humans, the pathogenesis remains 
elusive.  Here, we describe a new zebrafish mutant called skolios which develops spinal 
deformity that parallels many aspects of human idiopathic scoliosis.   
First, skolios mutants develop a complex, three-dimensional curvature of the spine 
without the presence of structural vertebral abnormalities.  In humans, idiopathic scoliosis is 
diagnosed only after other causes of scoliosis have been ruled out, including congenital vertebral 
defects or other syndromic diagnoses that can cause scoliosis (e.g. cerebral palsy, Marfan 
syndrome).  Vertebral defects were noted in some skolios mutants but were present at the same 
frequency in WT, suggesting curvature is unlinked to these vertebral abnormalities in skolios 
mutants.  Moreover, spinal curvature is the only phenotype observed in skolios mutants, 
suggesting that spinal curvature is not occurring secondary to a larger, systemic condition.   
Second, like human idiopathic scoliosis, we noted sexual dimorphism in skolios for the 
most severe curves.  In humans, mild idiopathic scoliosis affects males and females equally, but 
females develop severe deformity ten times more frequently than males [30].  In skolios, both 
genders were affected, but over time, adult male mutants developed a more severe spinal 
deformity compared to adult females.  Although this is opposite to the female bias observed in 
humans, it nevertheless demonstrates a role for gender in the progression of spinal deformity but 
not for overall susceptibility.   
Using meiotic mapping and low-coverage whole genome sequencing, we identified a 
nonsense mutation in kif6, a poorly characterized member of the kinesin family, as a candidate 
mutation for skolios.  Our results, along with others [13,31-33], demonstrate that low-coverage 
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whole genome sequencing is an effective approach to identify the genetic basis of a zebrafish 
mutant.  kif6 was confirmed as the causative gene by creating additional mutant alleles using 
TALENs that recapitulated both the embryonic and post-embryonic skolios phenotypes.  
Kinesins are motor proteins that have diverse function, but can be identified by their highly 
conserved motor domain that binds to microtubules and powers movement through the 
hydrolysis of ATP.  Using degenerate primers designed to this conserved motor domain, kif6 was 
first identified in cDNA from mouse hippocampus [34].  In a large mouse cDNA library, kif6 
was identified in spinal ganglion and cerebellum [35] and western blotting of mouse tissues has 
shown kif6 expression in various tissues, including brain and spinal cord [26].  Our expression 
analysis in zebrafish demonstrated similar results, with kif6 expressed in zebrafish brain, 
intestine, ovary and testis.  To our knowledge, this is the first demonstration of kif6 expression in 
zebrafish and the first demonstration of a mutant phenotype resulting from a mutation in kif6. 
Kif6 is poorly characterized and its function is unknown.  Most investigations of kif6 
have been limited to a common single nucleotide polymorphism (rs20455) in humans, which was 
associated with coronary artery disease [36-40], although a large meta-analysis failed to replicate 
the association [41] and the consequence of the common polymorphism in kif6 is currently being 
debated.  A kif6 mutant mouse was found to have normal cardiac function, while additional 
phenotypes were not described [26].  Kif6 was originally identified as an orphan kinesin [35,42], 
but has also been included with kinesin-family member 9 (kif9) in the Kinesin-9 superfamily.  
Although kif9 and kif6 share a region of conserved sequence near the kinesin motor domain that 
is specific to the Kinesin-9 superfamily [25], the proteins are phylogenetically distant [42].  
Members of the Kinesin-9 superfamily have only been identified in vertebrates and protozoa, 
which suggests they may be involved in cilia and flagella [25].   
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Further evidence for a role of kif6 in cilia was suggested by its downregulation in 
forebrain of forkhead box J1 (FoxJ1)-null mice [27], a transcription factor that is necessary and 
sufficient for motile cilia generation [43,44].  FoxJ1 is also required for the differentiation of 
ependymal cells [17], which are ciliated cells that line the ventricles in the brain and the central 
canal in the spinal cord.  Ependymal cells are responsible for circulating cerebral spinal fluid, 
although they may have additional functions.  In the Allen Brain Atlas (http://mouse.brain-
map.org/), kif6 expression is limited to the ependymal layer of the ventricle [17] and central 
canal of the spinal cord.  We did not find gross abnormalities in cilia formation or movement in 
the central canal and we did not identify additional cilia related phenotypes in skolios mutants 
(defects in left-right asymmetry, otolith abnormalities, hydrocephalus or kidney cysts), however 
these findings cannot rule out other cilia-related functions for kif6.  Curvature of the body axis is 
a common phenotype in zebrafish embryos with cilia defects [28] and has also been observed in 
adult cilia mutants [45], which is consistent with a cilia-related defect in skolios.  Cilia defects 
have been proposed as a mechanism for human idiopathic scoliosis [46], though scoliosis is not a 
common in human ciliopathies.  Future studies are needed to clarify the function of kif6 and the 
mechanism by which it leads to spinal curvature in skolios.  It is unclear whether kif6 mutations 
are important in the genesis of human idiopathic scoliosis.  Efforts aimed at identifying kif6 
mutations in a DNA database of pediatric patients with musculoskeletal disorders, including 
scoliosis, are currently underway (Christina Gurnett, personal communication).  
Overall, this study identifies skolios, a zebrafish mutant with spinal deformity.  The 
spinal curvature phenotype, which occurs isolated from other features and is not secondary to 
vertebral malformations suggests that skolios may serve as a model for human idiopathic 
scoliosis, which could be a valuable resource to better understand this complex human condition.  
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Moreover, we have established zebrafish as a viable model for spinal deformity that may be of 
use to confirm genetic findings in human studies of idiopathic scoliosis.  Using meiotic mapping 
and whole genome sequencing, we identify kif6 as genetic basis of skolios.  These finding 
highlight a new role for kif6 in spinal development and stability, expanding upon the already 
diverse cellular functions of kinesins.  
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Figure 4.1: Skolios mutants develop recessively-inherited curvature of the body axis 
(A) Ventral curvature phenotypes observed in skolios embryos at 3 dpf.  (B) Relative frequencies 
of ventral curvature phenotypes in WT and skolios embryos (3 dpf).  (C) Dorsal view of 
embryonic (4 dpf) and juvenile (17 dpf) zebrafish showing development of sagittal body 
curvature in skolios mutants.  (D) Severe body curvature in both the medial-lateral and dorsal-
ventral planes of an adult skolios mutant.  (E) MicroCT imaging at approximately 50 dpf shows 
marked curvature of the abdominal (rib vertebrae) and caudal (vertebrae posterior to ribs) spine 
in skolios mutants. 
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Figure 4.2: Spinal curvature in skolios mutants occurs independent of major vertebral 
abnormalities and is progressive through adult stages in males  
(A) Method of measuring spinal curve in zebrafish using skeletal histomorphology.  Lines were 
drawn through the middle of the two vertebrae adjacent to the apex of the curve.  The measured 
angle from the intersection was subtracted from 180° to calculate the spinal curve.  (B) Spinal 
curves measured for female skolios mutants at 2 (N=11), 5 (N=9), 7 (N=5) and 18 (N=5) mpf 
and male skolios mutants at 2 (N=10), 5 (N=8), 7 (N=5) and 18 (N=5) mpf.  The average spinal 
curve is shown for each time point.  At 2 mpf, males and females are similarly affected; 
however, by later stages, males continue to progress in severity.  *P<0.05.  (C) Skeletal 
histomorphology of a 2 mpf female WT and a skolios mutant with a 35° spinal curve near the 
transition from abdominal to caudal vertebrae that developed in the absence of vertebral fusions 
or other major vertebral abnormalities.  Box identifies region shown in A.   
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Figure 4.3: Vertebral fusions and malformations occur at similar frequencies in skolios and 
WT zebrafish 
(A) Zebrafish between 2-7 mpf were stained with Alizarin red to visualize individual vertebrae.  
Staining shows vertebral fusions (arrows) identified in WT and skolios.  (B) The overall 
frequency of vertebral fusions in skolios is similar to WT. 
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Figure 4.4: Meiotic mapping and whole genome sequencing identifies a nonsense mutation 
in kif6 as candidate for skolios 
(A) Summary of mapping experiments.  Two mapcrosses identified a ~3 Mb region on 
chromosome 17 harboring the causative genetic lesion for skolios.  (B) Gene and protein 
schematic of kif6 with the corresponding location of the nonsense mutation.  The G>T mutation 
(C>A in mRNA) in the second exon of kif6 causes a premature stop early in the kif6 protein 
sequence.  Kif6 protein domains are drawn according to the simple modular architecture research 
tool (SMART) [47].  The kinesin motor domain is shown, with grey bars indicating coiled-coil 
regions.  (C) Validation of the G>T mutation in skolios by Sanger sequencing.   
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Figure 4.5: Transient knockdown of kif6 using morpholinos 
WT zebrafish were injected with morpholinos at the 1-4 cell stage.  A morpholino targeting the 
kif6 translation start site but containing a 5 base mismatch (mismatch MO) served as a negative 
control.   
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Figure 4.6: Design and efficiency of kif6 TALENs 
(A) Genomic sequence showing left and right TALENs that were designed in the second exon of 
kif6 near the site of the nonsense mutation identified in skolios.  The TALEN pair flank a BccI 
restriction site.  (B) BccI restriction digest of PCR amplified DNA from WT embryos.  Embryos 
1-3 were not injected with kif6 TALENs and BccI cleaves the PCR product completely.  
Embryos 4-13 were injected with kif6 TALENs at the 1-4 cell stage and all embryos had varying 
levels of uncut product, indicating a mutation was induced at the BccI restriction site. (C) Three 
mutations identified in TALEN-injected embryos. 
 
  
123 
 
 
 
Figure 4.7: TALEN-induced mutations in kif6 recapitulate the skolios phenotype 
Zebrafish with TALEN-induced mutations in kif6 develop both embryonic and adult body axis 
curvature, similar to skolios mutants. 
 
 
 
  
124 
 
 
 
Figure 4.8: RT-PCR expression of kif6 in WT embryos and adult tissues  
(A) RT-PCR in WT zebrafish embryos shows low levels of kif6 between 24-120 hpf.  (B) RT-
PCR of various zebrafish tissues shows kif6 expression primarily in brain, intestine and 
reproductive organs.  
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Figure 4.9: Cilia structure and function are normal in skolios mutants  
(A) Defects in left-right asymmetry were evaluated by visualizing the position of the heart in 30 
hpf embryos for WT (N=94) and skolios mutants (N=173).  Normally, zebrafish hearts are 
located to the left of the midline (right side when viewed ventrally) at 30 hpf.  In zebrafish with 
ambiguous heart positioning, hearts appear at the midline and to the right side (left side when 
viewed ventrally) in zebrafish with situs inversus.  Ambiguous and inversed orientations of the 
heart were observed at similar frequencies in WT and skolios embryos.  (B) Otoliths were 
observed laterally in in 48-72 hpf zebrafish embryos.  Normal otolith numbers (two) and 
abnormal otolith numbers (one or three) were quantified WT (N=371) and skolios mutants 
(N=305).  (C) Whole-mount confocal immunostaining of 28 hpf WT and skolios embryos shows 
normal appearance of cilial in the central canal (arrows).  (D) Live 48 hpf WT and skolios 
embryos were injected with 5% tetramethylrhodamine conjugated to 70,000 molecular weight 
dextran.  Sixty minutes after injection, the dye has migrated similar distances in skolios mutants 
compared to WT embryos. 
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Table 4.1: Identification of candidate gene using low-coverage 
whole genome sequencing 
Sequencing and variant identification 
 101 bp paired-end reads 98,289,069 
 Aligned paired-end reads 65,990,507 
 ≥3X coverage  74%  
 Total genomic variants 8,043,651  
Variant filtering 
 Total variants in 2.7 Mb mapped locus 18,941 
 and absent in unrelated zebrafish with similar genetic background 4,166 
 and homozygous 3,156 
 and causing a nonsynonymous amino acid change 20 
 and causing a nonsense mutation (gene) 1 (kif6) 
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Discussion and Future Directions 
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 Scoliosis is a form of spinal deformity that causes the spine to curve abnormally in the 
frontal plane.  Although scoliosis occasionally arises as a secondary feature of a broader, 
systemic condition, most cases of scoliosis develop in late childhood with no known etiology and 
are classified as adolescent idiopathic scoliosis (AIS).  AIS is generally a mild condition, but for 
unknown reasons, about 10% of AIS patients develop progressive deformity and bracing or 
surgery is warranted to prevent negative physical and psychological outcomes.  Twin and family 
studies indicate a role for genetic factors in AIS development, but the identification of 
susceptibility loci using linkage, candidate gene and genome-wide association studies have 
yielded mixed and largely inconclusive findings.  Overall, the genetic basis of AIS remains 
poorly understood, which has been further challenged by the lack of a relevant animal model.   
 In this dissertation, we explored the role of rare variation in AIS, which had been largely 
unaddressed prior to the commencement of this work.  Specifically, we evaluated rare copy 
number variants (CNVs), chromosomal aneuploidy and rare coding variants (SNPs, INDELs) as 
genetic risk factors for AIS.  We also proposed that zebrafish (Danio rerio) is an excellent 
animal model to identify genetic and molecular pathways involved in spinal development.  While 
there is still much to be learned about the genetic basis of AIS, several general conclusions can 
be drawn from the results of the work presented here that will aid in future efforts to identify 
genetic risk factors and better understand AIS.  
 
1. AIS is complex disorder with complex genetics 
A major challenge addressing the genetic underpinnings of AIS has been the variable 
expressivity of the phenotype.  Individuals with AIS have substantial phenotypic variation; curve 
severity, age of onset, rates of progression and overall curve morphology can all differ 
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significantly among patients.  It is unclear to what degree genetic and environmental variation 
influences each of these features of AIS and if there are genetic risk factors that modify the AIS 
phenotype independent from overall susceptibility.   
Our findings support a role for genetic risk factors that act as disease modifiers.  In our 
exome sequencing study of rare coding variants, we identified rare missense mutations in FBN1 
(encoding fibrillin-1) and FBN2 (encoding fibrillin-2) that were strongly associated with curve 
severity in AIS patients.  These results pose a challenge to future investigations of AIS, as 
phenotypic variability among patients could hamper genetic studies by reducing the power of 
association or replication studies when case populations are highly heterogeneous.  Moreover, 
segregation analysis may be misinterpreted in such cases.  For example, if a genetic variant 
identified in a severely affected AIS patient is absent in a mildly affected family member, the 
variant may be deemed unimportant due to the failed segregation, but this result could also be 
consistent with the variant being a major disease modifier.  The complexity of the AIS phenotype 
should therefore be considered when assembling AIS patient cohorts to identify genetic risk 
factors for overall AIS susceptibility versus genetic modifiers that contribute to other variable 
features of AIS.  Because we have shown that genetic modifiers can impact curve severity, it 
would be interesting to evaluate other features of AIS that differ among patients (e.g. curve 
morphology, rates of progression). 
In addition to the interaction between genetic factors and a complex phenotype, we have 
also shown that those genetic factors are also complex, with many types of genetic variation 
contributing to AIS.  Previous genome-wide association studies have addressed the ‘common 
disease, common variant’ hypothesis (CDCV) and shown that common variants in LBX1 
(encoding ladybird homeobox 1) are associated with AIS in individuals of Asian ancestry [1-4].  
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An opposing theory, the ‘common disease, rare variant’ (CDRV) hypothesis, states that common 
diseases are due to rare variation of higher penetrance [5].  We show that the CDRV hypothesis 
is also a likely disease model for AIS development.  In our study of FBN1 and FBN2, we show 
that exceedingly rare coding variants were significantly associated with AIS.  Similarly, our 
analysis of copy number variation identified rare duplications of chromosome 1q21.1 and 
trisomy X that were enriched in AIS patients compared to controls.   
Collectively, these results indicate that many forms of genetic variation (e.g. CNVs, 
missense mutations), both common and rare, are significant genetic factors associated with AIS 
susceptibility and/or modifiers of AIS features (e.g. curve severity).  Future studies will therefore 
need to address multiple forms of genetic variation when evaluating AIS cases and stratify case 
populations to reduce heterogeneity. 
 
2. Several genes/loci conferring risk to AIS are  implicated in scoliosis-associated 
syndromes 
Our results suggest that genes already linked to disorders with high rates of scoliosis are 
good candidates for AIS.  As previously mentioned, we demonstrated an association with FBN1 
and FBN2 in AIS cases with severe deformity.   Mutations in FBN1 cause Marfan syndrome [6] 
and 63% of Marfan syndrome patients develop scoliosis [7].   However, Marfan syndrome also 
causes a variety of other symptoms, including aortic aneurysm and dissections, ectopia lentis, tall 
stature, pectus excavatum and carinatum, dolichostenomelia, arachnodactyly and joint 
hypermobility.  Mutations in FBN2 cause congenital contractural arachnodactyly (also called 
Beals syndrome) [8], and 50% of patients develop scoliosis [9], as well as “crumpled” ears, 
muscular hypoplasia, contractures of the major joints, pectus excavatum and carinatum, tall 
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stature, dolichostenomelia and arachnodactyly.  Disease-causing mutations in FBN1 and FBN2 
are thought to be highly penetrant and in FBN1, over 1,000 mutations have been described [10].  
Because both FBN1 and FBN2 already were linked to Mendelian disorders, it was surprising to 
discover an association with FBN1 and FBN2 and AIS.  Since Marfan syndrome and congenital 
contractural arachnodactyly both lead to scoliosis, we conclude that these specific mutations 
confer risk to isolated skeletal phenotypes such as scoliosis without additional disease features.   
A comparable finding was observed by Gao et al. [11] in CDH7 (encoding 
chromodomain helicase DNA-binding protein 7).  Mutations in CDH7 cause CHARGE 
syndrome (coloboma of the eye, heart defects, atresia of the choanae, retardation of growth 
and/or development, genital and/or urinary abnormalities, and ear abnormalities and deafness) 
[12] and >60% of CHARGE adolescent and adult patients develop scoliosis [11,13].  Sequencing 
CDH7 in 25 affected patients with AIS showed the minor allele of a common polymorphism 
(rs4738824) was significantly over-transmitted [11].  Although additional studies are needed in a 
larger case population to validate these findings, these results are consistent with variants 
affecting a gene (CDH7) typically associated with syndromic forms of scoliosis (CHARGE 
syndrome) also being a genetic risk factor for AIS. 
Similarly, duplications and deletions of 16p11.2 have been recently linked to scoliosis in 
individuals with a wide variety of other neurobehavioral and congenital abnormalities [14].  The 
16p11.2 locus was also identified by linkage analysis of 202 idiopathic scoliosis families [15,16] 
and Al-Kateb et al. [14] hypothesized that 16p11.2 could therefore be a novel susceptibility locus 
for idiopathic scoliosis.  Prior to the work presented here, 16p11.2 CNVs had not been described 
in an individual with isolated scoliosis.  We identified a duplication of chromosome 16p11.2 in a 
single AIS patient, providing preliminary evidence that 16p11.2 rearrangements can occur in a 
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scoliosis patient without the additional neurobehavioral and congenital abnormalities common to 
this genomic disorder.  Although additional studies containing larger patient cohorts will be 
needed to demonstrate an association with 16p11.2 rearrangements and AIS, this finding 
supports a role for the 16p11.2 locus in AIS susceptibility, despite causing a genomic disorder 
most often associated with many additional phenotypes. 
 Overall, our findings and others suggest that genes or loci causing systemic diseases 
associated with high rates of scoliosis (and many other symptoms) can be involved in the 
development of scoliosis as an isolated phenotype.  Future genetic studies of AIS should 
therefore focus on genes and molecular pathways associated with neuromuscular or syndromic 
forms of scoliosis.  For example, scoliosis is common to a number of Mendelian disorders, such 
as Ehlers-Danlos syndrome (caused by mutations in collagen genes) [17].  Loeys-Dietz 
syndrome is a dominant Mendelian disorder caused by mutations in the transforming growth 
factor-beta receptors, TGFβR1 and TGFβR2, that is also highly associated with scoliosis [18].  
Because Loeys-Dietz syndrome, like Marfan syndrome and congenital contractural 
arachnodactyly, alter the TGF-β pathway, TGFβR1 and TGFβR2 are especially good candidates 
to evaluate in future studies. 
 
3. A subset of AIS patients are undiagnosed for other conditions, but this is very rare 
In our CNV study, we identified two AIS patients with trisomy of the X chromosome, 
also called Triple X syndrome (47,XXX).  Triple X syndrome generally causes only mild 
phenotypes, which can include scoliosis [19].  As a result, many females with triple X syndrome 
are unaware of the condition [20].  The two females we identified with triple X syndrome 
represented <1% of all AIS females we evaluated for CNVs or chromosomal aneuploidy.  
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However, discovery of triple X syndrome allows clinicians to monitor other associated 
phenotypes (e.g. premature ovarian failure and developmental delay), so this finding is of clinical 
relevance despite its rarity.   
When we identified patients with rare variants in FBN1, we considered the possibility 
that these individuals were undiagnosed for Marfan syndrome.  In some cases, clinical 
recognition of Marfan syndrome is challenging due to large phenotypic variability among 
patients and nonspecific features.  Features that are most specific to Marfan syndrome (e.g. aortic 
dilation, ectopia lentis) are only identifiable though testing which is not routinely performed.  
Therefore, we referred AIS patients with rare variants in FBN1 for a thorough clinical 
examination by a clinical geneticist.  One patient with a previously described mutation in FBN1 
met the diagnostic criteria for Marfan syndrome after examination, representing only 0.3% of all 
AIS patients of European ancestry evaluated (N=311).  Marfan syndrome had not been 
previously suspected in this individual, but our finding is likely to be of great impact to the future 
health and management of this individual, as 90% of Marfan syndrome patients are affected with 
cardiac valve disease, aortic dissection, or congestive heart failure [21].   
Generally, the vast majority of AIS patients we evaluated were not found to have genetic 
or phenotypic findings suggestive of another diagnosis as a primary cause of scoliosis.  However, 
we have found that scoliosis can be attributed to a previously undiagnosed, underlying condition 
in a very small number of AIS patients.  This result was unexpected, as most syndromic forms of 
scoliosis occur simultaneously with additional, often easily recognized disease features.  Because 
many underlying diagnoses necessitate additional clinical care, future clinical and research 
studies involving AIS patients should make every attempt to rule out scoliosis-associated 
disorders like triple X syndrome and Marfan syndrome that can be difficult to recognize.        
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4. Genetic factors may predict AIS patients at risk for severe deformity 
Because AIS causes deformity in previously healthy children, a major long-term goal of 
AIS research is to identify methods to predict and ultimately prevent severe deformity.  One 
feasible approach to achieve this would be to identify genetic risk factors for severe deformity 
that could inform treatment strategies (e.g. bracing).  Idiopathic spinal deformity is common in 
the pediatric population, but not all individuals develop severe forms of disease and currently 
there is no method of predicting curve progression.  As a result, individuals with mild curvatures 
may be unnecessarily monitored and treated, whereas treatment may be delayed individuals at 
high risk of severe deformity.   
We have shown through our evaluation of FBN1 and FBN2 that 7.6% of patients of 
European ancestry had a rare variant in either gene and that these variants were significantly 
correlated to curve severity in a large cohort of AIS patients of European ancestry (N=405), 
which replicated in a cohort of Han Chinese AIS patients (N=370).  This indicates that FBN1 and 
FBN2 variants may be prognostic genetic markers to predict scoliosis progression and 
demonstrates the potential of identifying AIS patients for proactive treatment.  More studies will 
be needed to assess the clinical value and predictive value of identifying rare fibrillin variants, 
but our findings may be an important advance in our ability to identify patients at high risk of 
progressive deformity. 
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5. Zebrafish may be an ideal model to identify new genes involved in scoliosis/spine 
development and model genetic findings in human AIS 
A major challenge in understanding AIS has been the lack of a relevant animal model.  
Because zebrafish (Danio rerio) are highly tractable and have extensive genomic resources, 
zebrafish are particularly well-suited model organisms to model scoliosis.  Another teleost 
mutant, the guppy strain curveback, has been shown to develop non-induced spinal deformity 
[22], yet, spinal deformity in zebrafish has been largely unexplored.  We performed a forward 
genetic screen to identify zebrafish mutants with features of AIS.  From this screen, we identified 
skolios.  skolios mutants develop a medial-lateral curvature of the spine that arises independent 
of vertebral malformations, similar to humans with AIS.  Using meiotic mapping, low-coverage 
whole genome sequence and TALENs, we identified kif6 as the genetic basis of skolios.   
Overall, these results show that zebrafish are susceptible to AIS-like spinal curvature and 
therefore, zebrafish can be used as an animal model for AIS.  Our mutagenesis screen (a forward 
genetic approach) successfully identified a zebrafish mutant with an AIS-like phenotype.  We 
confirmed the genetic basis using the many useful tools available in zebrafish.  Moreover, these 
results suggest that zebrafish are suitable for reverse genetic screens.  In future studies, we hope 
to induce the genetic changes identified in AIS patients (e.g. FBN1 and FBN2 mutations) to 
determine their effect on the spinal column in zebrafish.   
 
In summary, we have provided evidence that rare duplications and deletions are genetic 
risk factors for AIS.  We have also shown that rare coding variants in FBN1 and FBN2 are 
associated with severe deformity and, as there are no reliable methods to predict progression in 
AIS patients, we hope these results will aid in our ability to develop future personalized 
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prevention strategies that might eliminate the need for surgery in AIS patients at high risk of 
severe deformity and to eliminate unnecessary screening and treatment for patients at low risk of 
progression.  Finally, we have demonstrate zebrafish as a viable animal model to study novel 
genetic and molecular pathways involved in spine development and to model genetic findings 
uncovered in human AIS populations.  The work presented here represents a significant advance 
in our understanding of AIS, which will be a primer for future studies aimed at elucidating the 
genetic basis and pathogenesis of AIS.   
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